<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-11T13:38:06+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-PHL-T-PBSP-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Intensifying and mainstreaming integrated DOTS in the Philippines project - Philippines (01-Jan-2014-31-Dec-2017)</narrative>
    </title>
    <description type="1">
      <narrative>Philippines, Tuberculosis, Philippine Business for Social Progress, Inc.</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To reduce TB prevalence and mortality beyond 55% by 2016 from the 1990 baseline in support of the Millenium Development Goals for poverty alleviation. Objectives: Increase case detection rate for TB all forms from 82% in 2012 to 90% in 2016; Increase MDR TB case detection rate from 22% in 2012 to 40% of estimated MDR TB cases among the notified TB cases in 2016; Increase Treatment Success Rate for MDR TB from 56% in 2009 to 75% in 2016; Sustain Treatment Success Rate for TB all forms at &gt;=90% in 2016.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Philippine Business for Social Progress, Inc.</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Philippine Business for Social Progress, Inc.</narrative>
    </participating-org>
    <other-identifier ref="PHL-T-PBSPP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2014-01-01" />
    <activity-date type="2" iso-date="2014-01-01" />
    <activity-date type="3" iso-date="2017-12-31" />
    <activity-date type="4" iso-date="2017-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Bryan Morris</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>bryan.morris@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="PH" percentage="100">
      <narrative>Philippines</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="249be4c6-1d80-43b4-b861-cadcf22badd8">
      <transaction-type code="2" />
      <transaction-date iso-date="2014-04-12" />
      <value currency="USD" value-date="2014-04-12">23477845.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="20ecb3c9-4f5b-4666-b14d-9fb8e91939f5">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-04-16" />
      <value currency="USD" value-date="2014-04-16">5087971.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0e650f98-d6e8-4fd6-b639-0495a75e749a">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-08-29" />
      <value currency="USD" value-date="2014-08-29">3151337.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a5d99730-3bc4-4225-bde1-ecc472c46560">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-08-29" />
      <value currency="USD" value-date="2014-08-29">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5790c147-e1cd-44e5-8a3b-966b6dfbdd19">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-11-27" />
      <value currency="USD" value-date="2014-11-27">7016315.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f08d0242-157d-4ff8-bd42-45748d213111">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-12-19" />
      <value currency="USD" value-date="2014-12-19">3232315.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7158158a-7c71-4460-8030-e5d1490bbe41">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-04-02" />
      <value currency="USD" value-date="2015-04-02">4724812.12</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1b57a682-8d61-4096-91de-1eb9bd437442">
      <transaction-type code="2" />
      <transaction-date iso-date="2015-04-27" />
      <value currency="USD" value-date="2015-04-27">26051353.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="72711535-5f5e-4429-8ee6-9136cbb5fc80">
      <transaction-type code="2" />
      <transaction-date iso-date="2015-04-27" />
      <value currency="USD" value-date="2015-04-27">-215094.88</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1203f125-48c5-42ad-b40b-b6239bc98f5f">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-04-30" />
      <value currency="USD" value-date="2015-04-30">7186625.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5e50b1b1-bf16-44ac-9439-8187ecf1b529">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-06-26" />
      <value currency="USD" value-date="2015-06-26">8530129.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7be1d9ae-183b-4709-9189-b7d53633146e">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-07-24" />
      <value currency="USD" value-date="2015-07-24">30000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e4ae5ae7-179d-4350-a43d-a1e062b7e16e">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-12-03" />
      <value currency="USD" value-date="2015-12-03">7580616.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="132c88c4-e9ca-4e94-b175-a2280694bac6">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-12-11" />
      <value currency="USD" value-date="2015-12-11">1895272.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="06a2dd23-beed-4c99-a06c-a836bd3bb63a">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-02-10" />
      <value currency="USD" value-date="2016-02-10">-828711.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="22485d19-76ae-4424-ae75-0ec0b1fb38f3">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-02-10" />
      <value currency="USD" value-date="2016-02-10">5891603.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="311fbf86-545a-4463-b4ea-1350769e3173">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-02-12" />
      <value currency="USD" value-date="2016-02-12">5891603.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e58407c2-2150-460f-bc03-244d2ed7caf0">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-05-30" />
      <value currency="USD" value-date="2016-05-30">22972801.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="dad1e32f-99c8-4976-9fcb-de1add8e9d5d">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-05-31" />
      <value currency="USD" value-date="2016-05-31">3370177.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="10bc27ab-c91e-45d7-b722-3a678eb5fd55">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-07-21" />
      <value currency="USD" value-date="2016-07-21">30000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6c7fc6bd-f8d1-4fb5-ba15-0aa7d303f281">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-07-21" />
      <value currency="USD" value-date="2016-07-21">8936405.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="93ded7c2-a7a6-4d95-8256-26cc887a5dad">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-10-13" />
      <value currency="USD" value-date="2016-10-13">674944.74</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="05be0a9e-fb40-4864-82f5-89db6433402a">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-10-28" />
      <value currency="USD" value-date="2016-10-28">17803798.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9c528478-5b36-4111-8bf7-82fab6bebe9f">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-10-28" />
      <value currency="USD" value-date="2016-10-28">-9961274.26</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7bcbce80-5ea7-4637-9c6e-d85f127782db">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-11-01" />
      <value currency="USD" value-date="2016-11-01">11982595.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5cc8f55a-683a-409a-8952-4126ca8aa4e2">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-12-02" />
      <value currency="USD" value-date="2016-12-02">1418206.15</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1311a60d-7940-45f9-a1d7-b2aca436c1fd">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-12-15" />
      <value currency="USD" value-date="2016-12-15">5821203.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="71979396-be63-4c42-86c9-5f8972d8e18c">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-12-15" />
      <value currency="USD" value-date="2016-12-15">-4402996.85</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8cbfee2f-0b80-48ba-92c3-894c35b314d5">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-01-06" />
      <value currency="USD" value-date="2017-01-06">20000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fde22ae5-6bf7-45d3-9c2d-35e2e2245988">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-01-06" />
      <value currency="USD" value-date="2017-01-06">5801203.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1fa4919f-4931-4c8d-8c02-21ce7425a01e">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-02-15" />
      <value currency="USD" value-date="2017-02-15">1209978.83</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="884d20ee-1751-46ab-a6b7-602ec6e2ef7d">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-02-23" />
      <value currency="USD" value-date="2017-02-23">1209978.83</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8cee52ba-6d3a-4536-9e4e-9a3200fe0750">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-05-01" />
      <value currency="USD" value-date="2017-05-01">13950030.84</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7c64cbf0-2016-4009-9dcb-178d10c6fd04">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-05-02" />
      <value currency="USD" value-date="2017-05-02">7127344.99</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9207826d-d24b-46b5-8e18-cf20cb2bed4f">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-05-18" />
      <value currency="USD" value-date="2017-05-18">2457470.39</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0e0a528d-008c-4094-9e92-024cd585a9f1">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-07-27" />
      <value currency="USD" value-date="2017-07-27">16276303.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6ba9c576-b7d2-4a85-8f4a-2440d77bde0a">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-07-27" />
      <value currency="USD" value-date="2017-07-27">-4365215.46</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a25936e4-662b-4010-8828-b4bc98d0ba16">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-28" />
      <value currency="USD" value-date="2017-07-28">6844840.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d326c659-30aa-4ba6-9797-39dffaa7041c">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-28" />
      <value currency="USD" value-date="2017-07-28">4689864.33</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4e79bbd5-220f-4df9-a47d-470f2199dffe">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-11-28" />
      <value currency="USD" value-date="2017-11-28">4741598.67</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e0e24c1c-a48b-46ae-9d7e-41fb21069c7a">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">50000.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8ff8676e-c0c3-4bff-b7c7-1e996559ccac">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9a0f243b-1a08-4bb7-9004-073cb6cc946c">
      <transaction-type code="7" />
      <transaction-date iso-date="2018-04-17" />
      <value currency="USD" value-date="2018-04-17">347628.62</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="30f5fc02-9f57-4448-b707-5dfdea34bd58">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-04-27" />
      <value currency="USD" value-date="2018-04-27">-347628.62</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4cc92435-1897-43f4-8494-ea46a59900f5">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-05-31" />
      <value currency="USD" value-date="2018-05-31">347629.40</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2a0e3481-a712-4d34-b951-35a53cb716b1">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-06-05" />
      <value currency="USD" value-date="2018-06-05">347629.40</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/PHL-T-PBSP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>MDR TB-other 1: Number and percentage of laboratories showing at least 95% proficiency for isoniazid and rifampicin drug susceptibility testing among the total number of laboratories that undertake drug susceptibility testing during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>MDR TB-other 1: Number and percentage of laboratories showing at least 95% proficiency for isoniazid and rifampicin drug susceptibility testing among the total number of laboratories that undertake drug susceptibility testing during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31">
          <comment>
            <narrative>Numerator: 3; Denominator: 7; Percentage: 42.9%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4; Denominator: 4; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3; Denominator: 4; Percentage: 75%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5; Denominator: 5; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4; Denominator: 5; Percentage: 80%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <actual>
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7; Denominator: 7; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7; Denominator: 7; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7; Denominator: 7; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8; Denominator: 9; Percentage: 88.9%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31">
          <comment>
            <narrative>Numerator: 1994; Denominator: 11469; Percentage: 17.4%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1425.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1409.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2850.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3032.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2183.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2412.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4365.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4788.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2589.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2784.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5600.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5771; Denominator: 5600; Percentage: 103%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3850.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3211.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7700.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6417.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31">
          <comment>
            <narrative>Numerator: 1807; Denominator: 11469; Percentage: 15.8%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1425.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1210.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2850.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2567.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2183.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1864.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4365.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4035.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2589.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2561.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5600.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5336; Denominator: 5600; Percentage: 95.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3850.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2913.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7700.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5684.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" ascending="0" aggregation-status="0">
        <title>
          <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="17" />
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target value="15" />
          <actual value="13" />
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="15" />
          <actual value="14" />
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="10" />
          <actual value="16" />
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="10" />
          <actual value="15.4" />
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="10" />
          <actual value="14.48">
            <comment>
              <narrative>Numerator: 270; Denominator: 1864.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="10" />
          <actual value="14.7">
            <comment>
              <narrative>Numerator: 591; Denominator: 4027.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="6" />
          <actual value="10.7">
            <comment>
              <narrative>Numerator: 273; Denominator: 2552.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="6" />
          <actual value="11.2">
            <comment>
              <narrative>Numerator: 310; Denominator: 2758.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>DOTS-other 1: Number and percentage of notified TB cases (all forms) contributed by non-NTP providers- private/ public sector</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>DOTS-other 1: Number and percentage of notified TB cases (all forms) contributed by non-NTP providers- private/ public sector</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="17.6">
          <comment>
            <narrative>Numerator: 39574; Denominator: 225361.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="1.4">
            <comment>
              <narrative>Numerator: 1560; Denominator: 108791.</narrative>
            </comment>
          </target>
          <actual value="0.9">
            <comment>
              <narrative>Numerator: 1033; Denominator: 108791.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="1.4">
            <comment>
              <narrative>Numerator: 3120; Denominator: 217581.</narrative>
            </comment>
          </target>
          <actual value="2.4">
            <comment>
              <narrative>Numerator: 5315; Denominator: 217581.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="4.6">
            <comment>
              <narrative>Numerator: 5160; Denominator: 111166.</narrative>
            </comment>
          </target>
          <actual value="6.3">
            <comment>
              <narrative>Numerator: 9334; Denominator: 147500.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="3.2">
            <comment>
              <narrative>Numerator: 7200; Denominator: 222331.</narrative>
            </comment>
          </target>
          <actual value="15">
            <comment>
              <narrative>Numerator: 12730; Denominator: 84867.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="6.4">
            <comment>
              <narrative>Numerator: 7200; Denominator: 112766.</narrative>
            </comment>
          </target>
          <actual value="9">
            <comment>
              <narrative>Numerator: 14254; Denominator: 158054.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="7">
            <comment>
              <narrative>Numerator: 8640; Denominator: 122659.</narrative>
            </comment>
          </target>
          <actual value="9.5">
            <comment>
              <narrative>Numerator: 14319; Denominator: 150239.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="7">
            <comment>
              <narrative>Numerator: 17280; Denominator: 245318.</narrative>
            </comment>
          </target>
          <actual value="9">
            <comment>
              <narrative>Numerator: 27450; Denominator: 304153.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="217354" />
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="108791" />
          <actual value="112106" />
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="217581" />
          <actual value="243379" />
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="111166" />
          <actual value="147500" />
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="222331" />
          <actual value="299207" />
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="112766" />
          <actual value="158054" />
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="122659" />
          <actual value="150239" />
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="245318" />
          <actual value="304153" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="99011" />
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="48955" />
          <actual value="46375" />
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="97911" />
          <actual value="99268" />
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="50025" />
          <actual value="50180" />
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="100049" />
          <actual value="101648" />
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="50744" />
          <actual value="55624" />
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="41704" />
          <actual value="55405" />
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="83408" />
          <actual value="113884" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="90">
          <comment>
            <narrative>Numerator: 75387; Denominator: 83413.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 42966; Denominator: 47740.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 85931; Denominator: 95479.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 44060; Denominator: 48956.</narrative>
            </comment>
          </target>
          <actual value="89.9">
            <comment>
              <narrative>Numerator: 84522; Denominator: 93993.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 88120; Denominator: 97911.</narrative>
            </comment>
          </target>
          <actual value="91.5">
            <comment>
              <narrative>Numerator: 74263; Denominator: 81130.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 45023; Denominator: 50025.</narrative>
            </comment>
          </target>
          <actual value="90.78">
            <comment>
              <narrative>Numerator: 37619; Denominator: 41442.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 90044; Denominator: 100049.</narrative>
            </comment>
          </target>
          <actual value="86.4">
            <comment>
              <narrative>Numerator: 77785; Denominator: 90044.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 45670; Denominator: 50744.</narrative>
            </comment>
          </target>
          <actual value="88.9">
            <comment>
              <narrative>Numerator: 48864; Denominator: 54982.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 91340; Denominator: 101488.</narrative>
            </comment>
          </target>
          <actual value="89.7">
            <comment>
              <narrative>Numerator: 99877; Denominator: 111373.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified TB cases, all forms, contributed by non-NTP providers - community referrals</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of notified TB cases, all forms, contributed by non-NTP providers - community referrals</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2011" iso-date="2011-12-31" value="0">
          <comment>
            <narrative>Numerator: 8500; Denominator: 214997.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="1.4">
            <comment>
              <narrative>Numerator: 3000; Denominator: 217581.</narrative>
            </comment>
          </target>
          <actual value="3.6">
            <comment>
              <narrative>Numerator: 7875; Denominator: 217581.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="1.9">
            <comment>
              <narrative>Numerator: 2130; Denominator: 111166.</narrative>
            </comment>
          </target>
          <actual value="7.9">
            <comment>
              <narrative>Numerator: 8768; Denominator: 111166.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="1.9">
            <comment>
              <narrative>Numerator: 4260; Denominator: 222331.</narrative>
            </comment>
          </target>
          <actual value="2.9">
            <comment>
              <narrative>Numerator: 6400; Denominator: 222331.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="7.8">
            <comment>
              <narrative>Numerator: 8760; Denominator: 112766.</narrative>
            </comment>
          </target>
          <actual value="11.02">
            <comment>
              <narrative>Numerator: 9356; Denominator: 84867.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="6.5">
            <comment>
              <narrative>Numerator: 14760; Denominator: 225531.</narrative>
            </comment>
          </target>
          <actual value="10.1">
            <comment>
              <narrative>Numerator: 15911; Denominator: 158054.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="5">
            <comment>
              <narrative>Numerator: 6000; Denominator: 122659.</narrative>
            </comment>
          </target>
          <actual value="4.3">
            <comment>
              <narrative>Numerator: 6427; Denominator: 150239.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="5">
            <comment>
              <narrative>Numerator: 12000; Denominator: 245318.</narrative>
            </comment>
          </target>
          <actual value="4.2">
            <comment>
              <narrative>Numerator: 12752; Denominator: 304150.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31">
          <comment>
            <narrative>Numerator: 11213; Denominator: 13386; Percentage: 83.8%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2218; Denominator: 2464; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5296; Denominator: 7377; Percentage: 71.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2454; Denominator: 2727; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 11213; Denominator: 13386; Percentage: 83.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <actual>
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2525; Denominator: 2805; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19991; Denominator: 20656; Percentage: 96.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 17693; Denominator: 19659; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26067; Denominator: 26437; Percentage: 98.6%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="80.9">
          <comment>
            <narrative>Numerator: 182; Denominator: 225.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 24; Denominator: 24.</narrative>
            </comment>
          </target>
          <actual value="45">
            <comment>
              <narrative>Numerator: 24; Denominator: 53.3.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 47; Denominator: 47.</narrative>
            </comment>
          </target>
          <actual value="73.7">
            <comment>
              <narrative>Numerator: 28; Denominator: 38.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 25; Denominator: 25.</narrative>
            </comment>
          </target>
          <actual value="90.6">
            <comment>
              <narrative>Numerator: 58; Denominator: 64.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 50; Denominator: 50.</narrative>
            </comment>
          </target>
          <actual value="80.9">
            <comment>
              <narrative>Numerator: 182; Denominator: 225.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 27; Denominator: 27.</narrative>
            </comment>
          </target>
          <actual value="87.98">
            <comment>
              <narrative>Numerator: 227; Denominator: 258.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 53; Denominator: 53.</narrative>
            </comment>
          </target>
          <actual value="85.5">
            <comment>
              <narrative>Numerator: 565; Denominator: 661.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 162; Denominator: 162.</narrative>
            </comment>
          </target>
          <actual value="92.5">
            <comment>
              <narrative>Numerator: 557; Denominator: 602.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 323; Denominator: 323.</narrative>
            </comment>
          </target>
          <actual value="93.9">
            <comment>
              <narrative>Numerator: 1199; Denominator: 1277.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="36.9">
          <comment>
            <narrative>Numerator: 3917; Denominator: 10618.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 23330; Denominator: 29163.</narrative>
            </comment>
          </target>
          <actual value="37">
            <comment>
              <narrative>Numerator: 23330; Denominator: 63054.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 46660; Denominator: 58325.</narrative>
            </comment>
          </target>
          <actual value="39.3">
            <comment>
              <narrative>Numerator: 4583; Denominator: 11664.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 24459; Denominator: 30574.</narrative>
            </comment>
          </target>
          <actual value="51.7">
            <comment>
              <narrative>Numerator: 10917; Denominator: 21115.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 48918; Denominator: 61148.</narrative>
            </comment>
          </target>
          <actual value="63.4">
            <comment>
              <narrative>Numerator: 37324; Denominator: 58887.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="80.1">
            <comment>
              <narrative>Numerator: 25644; Denominator: 32005.</narrative>
            </comment>
          </target>
          <actual value="79.5">
            <comment>
              <narrative>Numerator: 29864; Denominator: 37563.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 51287; Denominator: 64109.</narrative>
            </comment>
          </target>
          <actual value="82.7">
            <comment>
              <narrative>Numerator: 66007; Denominator: 79821.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 26926; Denominator: 33657.</narrative>
            </comment>
          </target>
          <actual value="85.4">
            <comment>
              <narrative>Numerator: 37503; Denominator: 43938.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 53852; Denominator: 67314.</narrative>
            </comment>
          </target>
          <actual value="83.8">
            <comment>
              <narrative>Numerator: 76734; Denominator: 91586.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new HIV-positive patients starting IPT during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new HIV-positive patients starting IPT during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="61.9">
          <comment>
            <narrative>Numerator: 1278; Denominator: 2064.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2014-01-01" />
          <period-end iso-date="2014-06-30" />
          <target value="60">
            <comment>
              <narrative>Numerator: 925; Denominator: 1542.</narrative>
            </comment>
          </target>
          <actual value="212.9">
            <comment>
              <narrative>Numerator: 711; Denominator: 334.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2014-07-01" />
          <period-end iso-date="2014-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 1850; Denominator: 3084.</narrative>
            </comment>
          </target>
          <actual value="66.4">
            <comment>
              <narrative>Numerator: 887; Denominator: 1336.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-01-01" />
          <period-end iso-date="2015-06-30" />
          <target value="60">
            <comment>
              <narrative>Numerator: 1081; Denominator: 1802.</narrative>
            </comment>
          </target>
          <actual value="59">
            <comment>
              <narrative>Numerator: 1063; Denominator: 1802.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 2162; Denominator: 3604.</narrative>
            </comment>
          </target>
          <actual value="61.9">
            <comment>
              <narrative>Numerator: 1278; Denominator: 2064.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="70">
            <comment>
              <narrative>Numerator: 1512; Denominator: 2160.</narrative>
            </comment>
          </target>
          <actual value="47.74">
            <comment>
              <narrative>Numerator: 941; Denominator: 1971.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 3024; Denominator: 4321.</narrative>
            </comment>
          </target>
          <actual value="68">
            <comment>
              <narrative>Numerator: 2938; Denominator: 4321.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="70">
            <comment>
              <narrative>Numerator: 1537; Denominator: 2195.</narrative>
            </comment>
          </target>
          <actual value="72.9">
            <comment>
              <narrative>Numerator: 1780; Denominator: 2442.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 3073; Denominator: 4390.</narrative>
            </comment>
          </target>
          <actual value="78">
            <comment>
              <narrative>Numerator: 3817; Denominator: 4894.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T13:38:06+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-PHL-T-PBSP-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Intensifying and Mainstreaming Integrated DOTS Project - Philippines (01-Jan-2018-31-Dec-2020)</narrative>
    </title>
    <description type="1">
      <narrative>Philippines, Tuberculosis, Philippine Business for Social Progress, Inc.</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Reduce TB burden by decreasing the number of TB deaths by 50% from 14,000 to 7,000 by 2022; Reduce TB burden by decreasing incidence rate by 24% from 322/100,000 population to 243/100,000 by 2022; Achieve zero TB-affected families facing catastrophic costs by 2022. Objectives: By 2022, increase TB treatment coverage to from 92% to 95% for DSTB and from 32% to 90% for DRTB; By 2022, achieve treatment success rate of 92% for DSTB cases and 85% for DRTB cases; By 2022, reduce catastrophic cost of TB-affected households accessing DOTS facilities to zero.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Philippine Business for Social Progress, Inc.</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Philippine Business for Social Progress, Inc.</narrative>
    </participating-org>
    <other-identifier ref="PHL-T-PBSPP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2018-01-01" />
    <activity-date type="2" iso-date="2018-01-01" />
    <activity-date type="3" iso-date="2020-12-31" />
    <activity-date type="4" iso-date="2020-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Bryan Morris</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>bryan.morris@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="PH" percentage="100">
      <narrative>Philippines</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="90.3">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="9.7">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="7.43">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9a33ca8-7a81-4232-9a19-1315956af36c" percentage="2.1">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="41f514b1-2e70-4f77-98c1-68e6052dc6a9" percentage="0.16">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7b99cb-f18c-499f-a55d-f7a0d6b99b21" percentage="27.24">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="46.09">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="7.48">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="a0ec8795-341f-4d7b-9bdd-618cfc782127" percentage="0.79">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="cbff055b-fbc0-468b-9604-e69b10cbd9dd" percentage="3.13">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="1a563d22-2c21-4f9a-b142-805695850ac9" percentage="2.86">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="56afe3f2-1fa3-4fd3-b845-9ea07f4bfd51" percentage="0.48">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="13c1e439-070b-4238-9903-7972703a027e" percentage="0.03">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Collaborative activities with other programs and sectors (TB/HIV)</narrative>
        </description>
      </budget-item>
      <budget-item code="755fd9d3-5219-420f-8cf5-d32af32e5180" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Community TB/HIV care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="03642497-8d31-43e6-9dc7-a1d83d6bad5e" percentage="0.72">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Engaging all care providers (TB/HIV)</narrative>
        </description>
      </budget-item>
      <budget-item code="92e11022-488c-4948-abb3-b61f3d9ca4f6" percentage="1.49">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2018-01-01" />
      <period-end iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-01-01">36049635.13</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">33607166.61</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">48887085.63</value>
    </budget>
    <capital-spend percentage="24.06" />
    <transaction ref="ac1c2520-f3b7-4d29-aac1-2f82ef70aae4">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-19" />
      <value currency="USD" value-date="2017-12-19">51293744.42</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="296af20c-3ea7-4ce8-a822-7b1ea61c2aea">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-20" />
      <value currency="USD" value-date="2017-12-20">5315436.10</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b205f4ed-dadc-4587-80a0-3e90c2cfbaed">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-03-09" />
      <value currency="USD" value-date="2018-03-09">7048103.79</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f129dd89-376f-4f0e-aee9-cea173a6cbe8">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-03-27" />
      <value currency="USD" value-date="2018-03-27">50000.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d48bae22-457d-46d1-b839-5667dfde57b0">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-05-08" />
      <value currency="USD" value-date="2018-05-08">6948938.32</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c1dfdeca-1df4-4745-bd07-2ed6e70b60e5">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-08-14" />
      <value currency="USD" value-date="2018-08-14">9286757.48</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5d3357df-8081-4af9-8e5e-fa2fe1ecc718">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-30" />
      <value currency="USD" value-date="2018-10-30">4184815.73</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c6041482-a9c3-4e48-8c1f-1371d15f9272">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-19" />
      <value currency="USD" value-date="2018-12-19">4544904.41</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d83a1e41-cd47-459b-8fe6-59d31e1a0e57">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4bd15a2e-23f6-4ca0-ba49-5f6e92acd7fb">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-01-15" />
      <value currency="USD" value-date="2019-01-15">1996000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1f3df9b3-dae3-4046-bf60-6c936e75b344">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-02-07" />
      <value currency="USD" value-date="2019-02-07">9207714.72</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8fc24ef9-b4cf-43b1-817a-dce9c953ac93">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-03-26" />
      <value currency="USD" value-date="2019-03-26">84041.10</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="face8509-4532-4e77-98fc-43c9f5219364">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-04-12" />
      <value currency="USD" value-date="2019-04-12">917751.19</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="228601e5-fd4d-4eba-9d4a-d3061f5efb85">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-06" />
      <value currency="USD" value-date="2019-05-06">47118170.98</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="71e4673f-0597-48ac-bd63-3eac13bd5599">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-06" />
      <value currency="USD" value-date="2019-05-06">-1759281.58</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5656ac2c-b25d-4570-ae5f-0dc337b172ab">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-07" />
      <value currency="USD" value-date="2019-05-07">50000.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7defcb01-1fde-4d66-9d41-ab4091985eed">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-05-09" />
      <value currency="USD" value-date="2019-05-09">6089787.42</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b2506087-0244-4143-8672-7fa04d9c3bb7">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-06-21" />
      <value currency="USD" value-date="2019-06-21">3862565.79</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fee8483f-c5cd-4c31-b0f1-564eed1b9517">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-07-19" />
      <value currency="USD" value-date="2019-07-19">5859514.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="257ed7fc-0e16-4a7e-bba9-5b01c47baf64">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-10-17" />
      <value currency="USD" value-date="2019-10-17">9354015.62</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0c967680-01db-4ce3-acc5-977eb64745db">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-12-13" />
      <value currency="USD" value-date="2019-12-13">9406477.93</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a9bdc18b-45c6-4ac8-b8fc-53a33a691034">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-01-16" />
      <value currency="USD" value-date="2020-01-16">2540155.49</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="39514b68-846d-47c9-b0da-dff45fb0bd00">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-01-23" />
      <value currency="USD" value-date="2020-01-23">598849.23</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="aee36e4c-c49d-41cc-8cbb-9e98624f05c4">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-01-30" />
      <value currency="USD" value-date="2020-01-30">35498.62</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="eec4d142-4d43-4ced-9d1f-0085a9731de4">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-13" />
      <value currency="USD" value-date="2020-02-13">2887828.86</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="40bf2fd8-988d-4446-97f3-bb6cf1106f62">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-18" />
      <value currency="USD" value-date="2020-02-18">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c8337422-d3b4-4bd8-ab95-af60e91173e7">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-02" />
      <value currency="USD" value-date="2020-04-02">6483478.02</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="939bdb51-2ed4-41b4-aec9-d4c2ff565b26">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-04-09" />
      <value currency="USD" value-date="2020-04-09">20000000.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bef53c3e-c47b-4c44-8a29-fae508224ae8">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-14" />
      <value currency="USD" value-date="2020-04-14">9403200.07</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e74f8e6c-f02c-46e9-ad22-5d7bb72860db">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-15" />
      <value currency="USD" value-date="2020-05-15">50000.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="38b61fab-81e6-4870-ab84-fa8098668731">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-06-16" />
      <value currency="USD" value-date="2020-06-16">4771036.68</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a6390f04-70eb-4216-affd-ae875ee962d3">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-30" />
      <value currency="USD" value-date="2020-06-30">7175472.20</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b4e7bd95-035a-4fde-8655-e7045d0fc8e6">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-30" />
      <value currency="USD" value-date="2020-06-30">-5825763.25</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="16aee6a6-0fe1-4dfd-b22d-6194cde589ef">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-07-08" />
      <value currency="USD" value-date="2020-07-08">5634309.87</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="11863417-c760-4ce4-a13c-e36141d08b6c">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-11-27" />
      <value currency="USD" value-date="2020-11-27">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="69419b05-9eef-4228-9b13-94938f6b54c3">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-22" />
      <value currency="USD" value-date="2020-12-22">1515990.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="14adbd92-1fa1-4840-8e22-84255434f7cb">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-10-01" />
      <value currency="USD" value-date="2021-10-01">17275.01</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="39d20650-43e3-45d5-9fea-783571c0e647">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-18" />
      <value currency="USD" value-date="2021-10-18">-17275.01</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b149d180-e95b-4a10-8478-5c5c40c4f778">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-01-20" />
      <value currency="USD" value-date="2022-01-20">7005.56</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9968b815-f81c-4bf4-8fcb-2afdeadcd66e">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-01-25" />
      <value currency="USD" value-date="2022-01-25">-7005.56</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d59bd518-9ceb-456d-8407-e109ddfc0ed0">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-07-26" />
      <value currency="USD" value-date="2022-07-26">-25172.33</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP02-EXP-20181231">
      <transaction-type code="4" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">36049635.16</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP02, Jan 2018 to Dec 2018.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP02-EXP-20191231">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-12-31">33607165.55</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP02, Jan 2019 to Dec 2019.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP02-EXP-20201231">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-12-31">48251360.25</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP02, Jan 2020 to Dec 2020.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP02-EXP-20210630">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-06-30" />
      <value currency="USD" value-date="2021-06-30">-6054568.36</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP02, Jan 2021 to Jun 2021.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/PHL-T-PBSP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 6417.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4568.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3386; Percentage: 74%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3217.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 31.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 956.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2292.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4569.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3295.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3267; Denominator: 3295; Percentage: 99.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 28; Denominator: 3295; Percentage: 0.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 977; Denominator: 3295; Percentage: 29.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2316; Denominator: 3295; Percentage: 70.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5290.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2594.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2559; Denominator: 2594; Percentage: 98.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 35; Denominator: 2594; Percentage: 1.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 889; Denominator: 2594; Percentage: 34.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1705; Denominator: 2594; Percentage: 65.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5291.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3858.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3827.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 31.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1183.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2675.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5195.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2819.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2796.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 23.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 882.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1937.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5195.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2524.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2504.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 20.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 772.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1752.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 5714.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5259.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1564.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3753.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 11.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 11.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 11.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 11.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 11.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 11.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4568.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3126; Percentage: 68%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3098.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 35.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 937.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2196.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 2345.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4569.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3158.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3130; Denominator: 3158; Percentage: 99.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 28; Denominator: 3158; Percentage: 0.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 940; Denominator: 3158; Percentage: 29.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2218; Denominator: 3158; Percentage: 70.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 2910; Denominator: 3158; Percentage: 92.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5290.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2674.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2648; Denominator: 2674; Percentage: 99%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 26; Denominator: 2674; Percentage: 1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 860; Denominator: 2674; Percentage: 32.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1814; Denominator: 2674; Percentage: 67.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 2282; Denominator: 2674; Percentage: 85.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4233.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3686.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3648.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 38.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1120.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2566.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 2388.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4156.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2665.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2646.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 19.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 812.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1853.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 1649.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4156.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2391.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2367.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 24.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 754.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1637.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 58.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" ascending="0" aggregation-status="0">
        <title>
          <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="16.18">
          <comment>
            <narrative>Numerator: 471; Denominator: 2911.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="12.99">
            <comment>
              <narrative>Numerator: 378; Denominator: 2911.</narrative>
            </comment>
          </target>
          <actual value="16.2">
            <comment>
              <narrative>Numerator: 471; Denominator: 2911.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="13">
            <comment>
              <narrative>Numerator: 594; Denominator: 4568.</narrative>
            </comment>
          </target>
          <actual value="16.4">
            <comment>
              <narrative>Numerator: 511; Denominator: 3110.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="11.99">
            <comment>
              <narrative>Numerator: 548; Denominator: 4569.</narrative>
            </comment>
          </target>
          <actual value="16.5">
            <comment>
              <narrative>Numerator: 518; Denominator: 3140.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="12">
            <comment>
              <narrative>Numerator: 635; Denominator: 5290.</narrative>
            </comment>
          </target>
          <actual value="11.7">
            <comment>
              <narrative>Numerator: 310; Denominator: 2650.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="11">
            <comment>
              <narrative>Numerator: 582; Denominator: 5291.</narrative>
            </comment>
          </target>
          <actual value="9">
            <comment>
              <narrative>Numerator: 329; Denominator: 3664.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="11">
            <comment>
              <narrative>Numerator: 632; Denominator: 5745.</narrative>
            </comment>
          </target>
          <actual value="4.7">
            <comment>
              <narrative>Numerator: 124; Denominator: 2660.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of confirmed MDR-TB cases tested for susceptibility to any fluoroquinolone and any second-line injectable drug</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of confirmed MDR-TB cases tested for susceptibility to any fluoroquinolone and any second-line injectable drug</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="42.68">
          <comment>
            <narrative>Numerator: 2439; Denominator: 5714.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 4568; Denominator: 4568.</narrative>
            </comment>
          </target>
          <actual value="90.2">
            <comment>
              <narrative>Numerator: 2821; Denominator: 3126.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 4569; Denominator: 4569.</narrative>
            </comment>
          </target>
          <actual value="95.2">
            <comment>
              <narrative>Numerator: 3005; Denominator: 3158.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 5290; Denominator: 5290.</narrative>
            </comment>
          </target>
          <actual value="97.9">
            <comment>
              <narrative>Numerator: 2618; Denominator: 2674.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 5291; Denominator: 5291.</narrative>
            </comment>
          </target>
          <actual value="97.4">
            <comment>
              <narrative>Numerator: 3589; Denominator: 3686.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 5745; Denominator: 5745.</narrative>
            </comment>
          </target>
          <actual value="88.3">
            <comment>
              <narrative>Numerator: 2354; Denominator: 2665.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 5745; Denominator: 5745.</narrative>
            </comment>
          </target>
          <actual value="90.9">
            <comment>
              <narrative>Numerator: 2173; Denominator: 2391.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="99.45">
          <comment>
            <narrative>Numerator: 3085; Denominator: 3102.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="93.91">
            <comment>
              <narrative>Numerator: 2913; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="99.1">
            <comment>
              <narrative>Numerator: 3065; Denominator: 3093.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="93.91">
            <comment>
              <narrative>Numerator: 2913; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="98.9">
            <comment>
              <narrative>Numerator: 3073; Denominator: 3108.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="95.87">
            <comment>
              <narrative>Numerator: 2974; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="97.6">
            <comment>
              <narrative>Numerator: 3047; Denominator: 3122.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="95.87">
            <comment>
              <narrative>Numerator: 2974; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="95.7">
            <comment>
              <narrative>Numerator: 2996; Denominator: 3129.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3102; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="90.5">
            <comment>
              <narrative>Numerator: 2848; Denominator: 3147.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3102; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="92.9">
            <comment>
              <narrative>Numerator: 2911; Denominator: 3135.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31">
          <comment>
            <narrative>Numerator: 686.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2422.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 713; Percentage: 29%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4042.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4256.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4922.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2533.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4922.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5452.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4922.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5996.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4922.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4497.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31">
          <comment>
            <narrative>Numerator: 1802.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1802; Percentage: 120%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1874.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2300.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1250.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2300.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2166.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1928.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 846.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1928.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1131.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="40529" />
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="2500" />
          <actual value="84" />
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="4120" />
          <actual value="5515" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="5000" />
          <actual value="5689" />
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="5000" />
          <actual value="5141" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="5000" />
          <actual value="3055" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="5000" />
          <actual value="2509" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 31778; Denominator: 198445; Percentage: 16.01%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 8000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6390; Percentage: 80%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19471.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 9000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 31778.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 30000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 33886.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 30000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19232.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 30000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 14547.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 332941.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 240705.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 240705.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 240705.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 240705.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 240705.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 240705.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 35967.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 35967.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 35967.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 35967.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 35967.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 35967.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 96250.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 96250.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 96250.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 96250.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 96250.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 96250.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 97541.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 97541.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 97541.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 97541.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 97541.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 97541.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 179131.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 179131.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 179131.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 179131.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 179131.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 179131.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 36863.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 36863.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 36863.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 36863.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 36863.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 36863.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 239554.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 239554.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 239554.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 239554.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 239554.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 239554.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 255.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 255.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 255.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 255.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 255.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 255.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 150423.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 160917; Percentage: 107%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 152541.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 18618.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 64146.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 59204.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 111955.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 40113.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 119576.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 636.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 193377.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 185540.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 162079; Denominator: 185432; Percentage: 87.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 23353; Denominator: 185432; Percentage: 12.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 66089; Denominator: 185432; Percentage: 35.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 66547; Denominator: 185432; Percentage: 35.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 118885; Denominator: 185432; Percentage: 64.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 40055; Denominator: 185432; Percentage: 21.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 99859; Denominator: 185432; Percentage: 53.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 598; Denominator: 185432; Percentage: 0.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 200550.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 198426.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 151261; Denominator: 198426; Percentage: 76.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 15255; Denominator: 198426; Percentage: 7.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 57123; Denominator: 198426; Percentage: 28.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 57820; Denominator: 198426; Percentage: 29.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 108696; Denominator: 198426; Percentage: 54.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 58972; Denominator: 198426; Percentage: 29.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 138763; Denominator: 198426; Percentage: 69.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 691; Denominator: 198426; Percentage: 0.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 200550.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 198513.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 177419.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 20310.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 72732.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 70625.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 127888.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 63586.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 134306.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 621.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 229200.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 147570.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 136131.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 11439.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 59920.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 49710.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 97860.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 45974.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 101178.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 418.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 229200.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 106680.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 209167.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 14792.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 107383.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 72101.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 151858.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 84688.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 138372.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 899.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="16.23">
          <comment>
            <narrative>Numerator: 54030; Denominator: 332941.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="30">
            <comment>
              <narrative>Numerator: 55783; Denominator: 185944.</narrative>
            </comment>
          </target>
          <actual value="34">
            <comment>
              <narrative>Numerator: 55972; Denominator: 164463.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="30">
            <comment>
              <narrative>Numerator: 55783; Denominator: 185944.</narrative>
            </comment>
          </target>
          <actual value="46.8">
            <comment>
              <narrative>Numerator: 77542; Denominator: 165753.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 105795; Denominator: 211590.</narrative>
            </comment>
          </target>
          <actual value="29.4">
            <comment>
              <narrative>Numerator: 48593; Denominator: 165461.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 105795; Denominator: 211590.</narrative>
            </comment>
          </target>
          <actual value="52">
            <comment>
              <narrative>Numerator: 103133; Denominator: 198513.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 188549; Denominator: 235687.</narrative>
            </comment>
          </target>
          <actual value="70.6">
            <comment>
              <narrative>Numerator: 90725; Denominator: 128586.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 188549; Denominator: 235687.</narrative>
            </comment>
          </target>
          <actual value="64.2">
            <comment>
              <narrative>Numerator: 71084; Denominator: 110677.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 286811; Denominator: 315225; Percentage: 90.99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 149614; Denominator: 280562; Percentage: 53.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 149614; Denominator: 280562; Percentage: 53.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 149614; Denominator: 280562; Percentage: 53.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 149614; Denominator: 280562; Percentage: 53.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 149614; Denominator: 280562; Percentage: 53.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 149614; Denominator: 280562; Percentage: 53.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 27501; Denominator: 48643; Percentage: 56.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 27501; Denominator: 48643; Percentage: 56.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 27501; Denominator: 48643; Percentage: 56.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 27501; Denominator: 48643; Percentage: 56.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 27501; Denominator: 48643; Percentage: 56.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 27501; Denominator: 48643; Percentage: 56.54%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 112846; Denominator: 122659; Percentage: 92%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 139740; Denominator: 154623; Percentage: 90.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 36363.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 86.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 112846; Denominator: 122659; Percentage: 92%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 137881; Denominator: 147035; Percentage: 93.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 122070; Denominator: 140375; Percentage: 87%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 18305; Denominator: 140375; Percentage: 13%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 139893; Denominator: 150423; Percentage: 93%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 146198; Denominator: 161740; Percentage: 90.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 132989; Denominator: 150143; Percentage: 88.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 17154; Denominator: 150143; Percentage: 11.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 139893; Denominator: 150423; Percentage: 93%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 143326; Denominator: 158620; Percentage: 90.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 138270; Denominator: 148678; Percentage: 93%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 151351; Denominator: 169076; Percentage: 89.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 189433.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 22516.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 138270; Denominator: 148678; Percentage: 93%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 145610; Denominator: 198198; Percentage: 73.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 274820.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 29145.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="92.95">
          <comment>
            <narrative>Numerator: 633; Denominator: 681.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 568; Denominator: 568.</narrative>
            </comment>
          </target>
          <actual value="96.9">
            <comment>
              <narrative>Numerator: 620; Denominator: 640.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 568; Denominator: 568.</narrative>
            </comment>
          </target>
          <actual value="95.4">
            <comment>
              <narrative>Numerator: 666; Denominator: 698.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 664; Denominator: 664.</narrative>
            </comment>
          </target>
          <actual value="98.2">
            <comment>
              <narrative>Numerator: 820; Denominator: 835.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 664; Denominator: 664.</narrative>
            </comment>
          </target>
          <actual value="96.9">
            <comment>
              <narrative>Numerator: 869; Denominator: 897.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 767; Denominator: 767.</narrative>
            </comment>
          </target>
          <actual value="97.1">
            <comment>
              <narrative>Numerator: 663; Denominator: 683.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 767; Denominator: 767.</narrative>
            </comment>
          </target>
          <actual value="95.1">
            <comment>
              <narrative>Numerator: 329; Denominator: 346.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="98.6">
          <comment>
            <narrative>Numerator: 26067; Denominator: 26437.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 21519; Denominator: 23910.</narrative>
            </comment>
          </target>
          <actual value="95.9">
            <comment>
              <narrative>Numerator: 28153; Denominator: 29348.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 21520; Denominator: 23911.</narrative>
            </comment>
          </target>
          <actual value="96.3">
            <comment>
              <narrative>Numerator: 33198; Denominator: 34464.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 29409; Denominator: 32677.</narrative>
            </comment>
          </target>
          <actual value="93.1">
            <comment>
              <narrative>Numerator: 34031; Denominator: 36565.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 29409; Denominator: 32677.</narrative>
            </comment>
          </target>
          <actual value="96.6">
            <comment>
              <narrative>Numerator: 30468; Denominator: 31530.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 39017; Denominator: 43352.</narrative>
            </comment>
          </target>
          <actual value="95.8">
            <comment>
              <narrative>Numerator: 42822; Denominator: 44681.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 39017; Denominator: 43352.</narrative>
            </comment>
          </target>
          <actual value="96">
            <comment>
              <narrative>Numerator: 42767; Denominator: 44553.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="67.99">
          <comment>
            <narrative>Numerator: 2938; Denominator: 4321.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="70">
            <comment>
              <narrative>Numerator: 3873; Denominator: 5533.</narrative>
            </comment>
          </target>
          <actual value="67.3">
            <comment>
              <narrative>Numerator: 1767; Denominator: 2624.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 3873; Denominator: 5533.</narrative>
            </comment>
          </target>
          <actual value="63.7">
            <comment>
              <narrative>Numerator: 1944; Denominator: 3050.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="70">
            <comment>
              <narrative>Numerator: 4191; Denominator: 5987.</narrative>
            </comment>
          </target>
          <actual value="65.9">
            <comment>
              <narrative>Numerator: 2106; Denominator: 3197.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 4191; Denominator: 5987.</narrative>
            </comment>
          </target>
          <actual value="70">
            <comment>
              <narrative>Numerator: 3008; Denominator: 4300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="70">
            <comment>
              <narrative>Numerator: 4594; Denominator: 6563.</narrative>
            </comment>
          </target>
          <actual value="60.9">
            <comment>
              <narrative>Numerator: 1463; Denominator: 2402.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="69.99">
            <comment>
              <narrative>Numerator: 4593; Denominator: 6562.</narrative>
            </comment>
          </target>
          <actual value="63.1">
            <comment>
              <narrative>Numerator: 2652; Denominator: 4200.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="83.78">
          <comment>
            <narrative>Numerator: 76734; Denominator: 91586.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="83">
            <comment>
              <narrative>Numerator: 71017; Denominator: 85563.</narrative>
            </comment>
          </target>
          <actual value="85.2">
            <comment>
              <narrative>Numerator: 42175; Denominator: 49528.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="83">
            <comment>
              <narrative>Numerator: 71017; Denominator: 85563.</narrative>
            </comment>
          </target>
          <actual value="86.2">
            <comment>
              <narrative>Numerator: 46215; Denominator: 53625.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 82998; Denominator: 97645.</narrative>
            </comment>
          </target>
          <actual value="81.2">
            <comment>
              <narrative>Numerator: 66469; Denominator: 81820.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 82998; Denominator: 97645.</narrative>
            </comment>
          </target>
          <actual value="89.5">
            <comment>
              <narrative>Numerator: 71685; Denominator: 80069.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="87">
            <comment>
              <narrative>Numerator: 95854; Denominator: 110177.</narrative>
            </comment>
          </target>
          <actual value="89">
            <comment>
              <narrative>Numerator: 73520; Denominator: 82644.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="87">
            <comment>
              <narrative>Numerator: 95854; Denominator: 110177.</narrative>
            </comment>
          </target>
          <actual value="70.9">
            <comment>
              <narrative>Numerator: 31718; Denominator: 44712.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T13:38:06+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-PHL-T-PBSP-3</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Advancing Client-centered Care and Expanding Sustainable Services for TB - Philippines (01-Jan-2021-31-Dec-2023)</narrative>
    </title>
    <description type="1">
      <narrative>Philippines, Tuberculosis, Philippine Business for Social Progress, Inc.</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Decrease TB deaths  from 26,000 in 2018 to 22,000 in 2023; Achieve zero TB-affected families facing catastrophic costs by 2023; Decrease TB Incidence by 12% from 554 per 100,000 population in 2018 to 488 per 100,000 population in 2023. Objectives: By 2023, achieve screening of at least 162 million people for TB either through symptom screening or chest x-ray; By 2023, test at least 14 million presumptive TB with WHO recommended rapid diagnostic tool; By 2023, initiate treatment for 2 million people with active TB, including 50,000 DRTB cases; By 2023, successfully treat 90% of DSTB patients and 85% of DRTB patients; By 2023, provide TB preventive therapy to 752,000 eligible patients.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Philippine Business for Social Progress, Inc.</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Philippine Business for Social Progress, Inc.</narrative>
    </participating-org>
    <other-identifier ref="PHL-T-PBSPP03" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2021-01-01" />
    <activity-date type="2" iso-date="2021-01-01" />
    <activity-date type="3" iso-date="2023-12-31" />
    <activity-date type="4" iso-date="2023-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Bryan Morris</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>bryan.morris@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="PH" percentage="100">
      <narrative>Philippines</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="80.62">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="19.38">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="6a7cb452-4c5d-49b6-aa43-8437d24fa1c5" percentage="0.38">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="12.32">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="1.67">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="7d2483ee-e340-40e2-8f81-88b761c385aa" percentage="0.16">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="5c6d2150-43bf-412f-a249-05dbaa402867" percentage="0.86">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Procurement capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="45f58950-e70b-425c-a83d-28115a57a936" percentage="0.18">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Regulatory/quality assurance support</narrative>
        </description>
      </budget-item>
      <budget-item code="4078713e-8351-4887-be1a-1617bf48ccd5" percentage="1.05">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector governance and planning -&gt; National health sector strategies and financing</narrative>
        </description>
      </budget-item>
      <budget-item code="0651e028-d13e-4937-8777-a97183a5b108" percentage="2.75">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; Laboratory supply chain systems</narrative>
        </description>
      </budget-item>
      <budget-item code="30f85a5d-1110-4276-932f-a742fc65c90f" percentage="10.47">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="452ec704-0b92-43c1-9cac-6649d925fde1" percentage="0.56">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Collaborative activities with other programs and sectors (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="9a89bb7c-0497-4574-b9d1-dd46b1823c81" percentage="1.2">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Engaging all care providers (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="8194063f-1bf8-4be2-9ebd-2823d5ac44a3" percentage="42.05">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="75ab2142-781a-4a2a-b8e0-50e6a129924b" percentage="0.54">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Community mobilization and advocacy (TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="95aeb1ae-4531-4aec-8557-537759098b9c" percentage="0.12">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Legal literacy ("Know Your Rights")</narrative>
        </description>
      </budget-item>
      <budget-item code="b108d9bd-d341-43a6-a473-1be4efabc458" percentage="0.65">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Stigma and discrimination reduction (TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="3.75">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="e5d69248-af9e-44de-a99d-c2557c675f55" percentage="6.11">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="3d30473b-46e8-4203-ad93-10040d8517cb" percentage="9.67">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="87435fc1-d92b-4039-b203-96061e6e85be" percentage="2.18">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="0.63">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="f9ff8a94-1fc1-4acf-863f-a191df107ee9" percentage="1.33">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Engaging all care providers (TB/HIV)</narrative>
        </description>
      </budget-item>
      <budget-item code="2146ce4f-9254-4a2a-8be8-e14734ab53dc" percentage="1.36">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="d5851297-913c-4ce3-a373-c0915334727a" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">37323897.48</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">58637843.02</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">73005530.70</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">17983840.45</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">4240953.42</value>
    </budget>
    <capital-spend percentage="16.49" />
    <transaction ref="e570daed-1340-4868-a56b-65c0c19c7254">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-12-16" />
      <value currency="USD" value-date="2020-12-16">67281202.96</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0a72ab37-f4b2-4307-b2d3-e5266904b625">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-22" />
      <value currency="USD" value-date="2020-12-22">8922352.30</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4286bf3e-a9b7-4174-a22c-54c0564b3e21">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-02-12" />
      <value currency="USD" value-date="2021-02-12">1575412.80</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4ffed38f-5764-4432-af8a-3089f114f190">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-05" />
      <value currency="USD" value-date="2021-03-05">166358.99</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="64368d7e-be24-4695-8f67-ad3e555d7219">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-09" />
      <value currency="USD" value-date="2021-04-09">95549.84</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="223456c6-56e9-4728-8d7b-a6231feaab0e">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-05-07" />
      <value currency="USD" value-date="2021-05-07">11346876.15</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="97b2eeb7-22d3-4b65-afe1-905a7b0e1656">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-07" />
      <value currency="USD" value-date="2021-07-07">119009.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aaab8a78-a369-401b-a94e-0cfac5907f75">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-07" />
      <value currency="USD" value-date="2021-07-07">50000.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="db409cc7-8362-409c-9470-76aba5d81dcc">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-15" />
      <value currency="USD" value-date="2021-07-15">81600.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="db681d89-b3a8-4dc7-be14-3ff11f66d991">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-15" />
      <value currency="USD" value-date="2021-07-15">37409.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="f526ecf9-0114-4a9f-8901-8d1557013e69">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-08-04" />
      <value currency="USD" value-date="2021-08-04">45533.37</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="33f9881b-80df-4b7f-b958-04141e6a83b9">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-08-05" />
      <value currency="USD" value-date="2021-08-05">9639066.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d07cf24d-e78b-45c3-bc08-b83157dcdcd6">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-08-05" />
      <value currency="USD" value-date="2021-08-05">4081338.36</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c1af1747-eded-4179-b920-7901ccfbea20">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-08-11" />
      <value currency="USD" value-date="2021-08-11">8507985.94</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4d681903-8484-4ce3-80d8-63f2498079f5">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-21" />
      <value currency="USD" value-date="2021-09-21">8507985.94</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d3522e05-3ae1-48ec-85c7-9d1b3095d98a">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">-8626994.94</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="80733d48-aeb6-4069-923f-ea6f55354cf6">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">8626994.94</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3a81ef11-ca44-404c-a950-2136de51506d">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">-45533.37</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6c2690af-a552-4c34-b5de-6df925347539">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">-8626994.94</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0544d59c-6841-49a1-a661-7ab189542bdc">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">8626994.94</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6faf4961-5eba-48b3-ab75-eb8a0d6ea4e0">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">45533.37</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3becd0e8-d31d-4aa1-a135-e46e018a7a81">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-19" />
      <value currency="USD" value-date="2021-10-19">8507985.94</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3d89dafc-df12-469a-9d49-4e9bc8dc9be9">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-19" />
      <value currency="USD" value-date="2021-10-19">81600.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="54f92380-4136-4156-8e25-7b073621c02b">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-10-19" />
      <value currency="USD" value-date="2021-10-19">8626994.94</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="75c01336-105f-4f14-b7b2-4ace744a4315">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-19" />
      <value currency="USD" value-date="2021-10-19">37409.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d22843b9-02cb-4312-92c6-a986d6c20433">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-19" />
      <value currency="USD" value-date="2021-10-19">1019372.31</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f7851226-019e-44cc-8f3a-ca462b6caa73">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-21" />
      <value currency="USD" value-date="2021-10-21">2475143.85</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a2aa3ac5-fd7e-4125-82df-9ba9ae988dea">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-04" />
      <value currency="USD" value-date="2021-11-04">8205113.94</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ed5ad7f3-6b0d-44d3-a877-62016f78ebac">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-04" />
      <value currency="USD" value-date="2021-11-04">1653688.02</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="05de58bc-a72f-4fee-9ba8-00424dcbea0c">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-20" />
      <value currency="USD" value-date="2021-11-20">867553.91</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="095094f0-e7e1-4e8f-ab2c-8a16db967f7a">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-20" />
      <value currency="USD" value-date="2021-11-20">-1019372.31</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a179cac6-d6a0-4347-9b2f-bb46212c6a29">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-22" />
      <value currency="USD" value-date="2021-11-22">28856.13</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="2fcd52c4-2beb-40d8-a225-69c7838bb81a">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-03" />
      <value currency="USD" value-date="2021-12-03">10854.66</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f26a70b9-087f-498c-822c-089f5fddb1af">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-03" />
      <value currency="USD" value-date="2021-12-03">-10854.66</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="66d92d3e-134b-4907-a95b-6288298e121b">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-04" />
      <value currency="USD" value-date="2021-12-04">-867553.91</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ba6abf74-094a-4f1d-b67e-9f55dd6662b0">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-04" />
      <value currency="USD" value-date="2021-12-04">1057694.71</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="687a4767-9e92-4662-b782-04fb61dcb5bb">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-12-08" />
      <value currency="USD" value-date="2021-12-08">10854.66</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="38a36b15-ffa3-4600-86ad-1c129abb3bd0">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-14" />
      <value currency="USD" value-date="2021-12-14">-16677.24</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="406fe08a-df6a-462d-b744-bf57bffd5df9">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-14" />
      <value currency="USD" value-date="2021-12-14">651299.62</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bac042b8-f40e-4275-905d-b80bc057966e">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-01-12" />
      <value currency="USD" value-date="2022-01-12">5767.75</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="5e3e967e-7254-4447-aac8-52f723c30e84">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-01-20" />
      <value currency="USD" value-date="2022-01-20">7635.90</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ff5cb919-81e9-4748-bee4-30d261edc65f">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-01-25" />
      <value currency="USD" value-date="2022-01-25">-7635.90</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="88e80e38-2ddc-48d1-9da4-625e045f500c">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-01-29" />
      <value currency="USD" value-date="2022-01-29">-10854.66</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7233c747-95f0-41fe-9dd1-529d6d2cb121">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-02-02" />
      <value currency="USD" value-date="2022-02-02">88769.28</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0b4db668-ac4f-488f-9795-cd4d247b49b0">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-25" />
      <value currency="USD" value-date="2022-02-25">100000.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7957e33e-ce51-4185-a1a9-d026d9f268e0">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-25" />
      <value currency="USD" value-date="2022-02-25">-50000.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9a8aaaee-f20c-4fb1-83bd-f262481eb39b">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-03-09" />
      <value currency="USD" value-date="2022-03-09">51483.97</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="deafcb67-875c-4242-bf48-f658f631e3de">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-03-09" />
      <value currency="USD" value-date="2022-03-09">-51483.97</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4a869c16-04aa-46a8-ac66-ba67bc06b0d5">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-14" />
      <value currency="USD" value-date="2022-03-14">13996.25</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b6b1e54d-c3ab-4718-82a0-7ec4cd5cb356">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-14" />
      <value currency="USD" value-date="2022-03-14">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="69d1208d-47e0-4789-8275-b8c653b2cf97">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-24" />
      <value currency="USD" value-date="2022-03-24">16180904.98</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f9689828-6c2b-4de4-b09d-22caa1bdf1e8">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-25" />
      <value currency="USD" value-date="2022-03-25">243394.12</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a8a4c093-57eb-4815-9049-32954ae4016b">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-03-26" />
      <value currency="USD" value-date="2022-03-26">-542766.34</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ba66ba0b-2291-49a5-af52-45f1e3b662b0">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-03-26" />
      <value currency="USD" value-date="2022-03-26">531856.85</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c9a33d41-f17f-4e71-9ac7-95fcbe3e1372">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-03-29" />
      <value currency="USD" value-date="2022-03-29">51483.97</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a85b985d-b5da-44d3-9187-9737e7312b57">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-04-20" />
      <value currency="USD" value-date="2022-04-20">332297.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="dc685f62-75bb-4a45-8fb2-4a2771ce44d6">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-04-24" />
      <value currency="USD" value-date="2022-04-24">-51483.97</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="56783b13-c919-4d71-ad9b-6d2cd16287f1">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-04-28" />
      <value currency="USD" value-date="2022-04-28">106170.78</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9106be70-0cf8-449f-a722-24fcd721270b">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-05-12" />
      <value currency="USD" value-date="2022-05-12">-2833226.95</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="98fdd9bc-de8f-4608-a830-f20660032144">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-05-12" />
      <value currency="USD" value-date="2022-05-12">11391551.31</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="99887cae-0470-4c92-9ac8-e32863bcc40f">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-18" />
      <value currency="USD" value-date="2022-05-18">158259.68</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d02593e3-6e14-49e0-b810-78f4803ee387">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">7095584.31</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="15f05fe2-5a7c-483d-8bee-ad27148fb266">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-25" />
      <value currency="USD" value-date="2022-05-25">119634.72</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0c15d04e-6556-46f2-8f46-d36dc184cb8b">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-05-31" />
      <value currency="USD" value-date="2022-05-31">127411.07</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="33830b0c-5bfb-4b8f-951f-94efc6b70057">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-05-31" />
      <value currency="USD" value-date="2022-05-31">-199559.85</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1bf6c64f-ae91-4d96-be6a-a89663670f81">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-16" />
      <value currency="USD" value-date="2022-06-16">32520.04</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="76b4ad99-5b1e-490e-9d1b-1d7188ce3a0b">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-18" />
      <value currency="USD" value-date="2022-06-18">4651132.28</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="94d5d0a9-5c54-4578-b849-bddaace63dfc">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-18" />
      <value currency="USD" value-date="2022-06-18">-536406.19</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="add25503-be67-449b-8ae9-14f199a9b3b2">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-22" />
      <value currency="USD" value-date="2022-06-22">12061808.99</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ea3560d4-51a4-4e31-9f52-437c19d5e50c">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-22" />
      <value currency="USD" value-date="2022-06-22">-4295967.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0b8daef2-c9b9-4937-b3e4-4dd699a288f5">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-27" />
      <value currency="USD" value-date="2022-06-27">3355360.63</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="062a7aaf-e4ed-489c-890b-906b6a18cede">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-04" />
      <value currency="USD" value-date="2022-08-04">2185985.01</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c3cb7e74-0000-4b77-b5c6-9c7e5a8e0c00">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-04" />
      <value currency="USD" value-date="2022-08-04">129368.48</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3dbae79c-38bb-4656-be17-f47453d824fb">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-08-11" />
      <value currency="USD" value-date="2022-08-11">2346264.53</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4adf7349-907e-42d5-8563-7a6a369a4497">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-08-11" />
      <value currency="USD" value-date="2022-08-11">-2335778.79</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f5f00004-50be-4fb8-8f86-d88b5e57087f">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-08-11" />
      <value currency="USD" value-date="2022-08-11">-10485.74</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b46f1fea-da9c-4d15-9e70-f9fddc5b83ba">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-22" />
      <value currency="USD" value-date="2022-08-22">31017.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="f37d576d-4087-4d43-8484-b87966a78a9d">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-08-22" />
      <value currency="USD" value-date="2022-08-22">10485.74</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5b6d006e-ebca-4faa-babf-dba481085454">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-09-06" />
      <value currency="USD" value-date="2022-09-06">2297314.98</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5ba1a4a3-b9da-4ef8-82bb-b03506ab1ad4">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-09-06" />
      <value currency="USD" value-date="2022-09-06">-2315247.53</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d6ddfea5-1c4b-4852-8c58-c66eff51d204">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-10-01" />
      <value currency="USD" value-date="2022-10-01">9293.86</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2701461e-aff4-44aa-8471-aa6cbb34247b">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-19" />
      <value currency="USD" value-date="2022-10-19">-9293.86</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="46df63cf-77fe-4b06-9981-dde4c6c9f6d8">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-27" />
      <value currency="USD" value-date="2022-10-27">43451096.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a361f8c8-70c8-468c-b59a-9f60b238b018">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-27" />
      <value currency="USD" value-date="2022-10-27">-8706448.36</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4e75dcd4-0dc8-4944-9ffa-d3e4f6d57bd7">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-01" />
      <value currency="USD" value-date="2022-11-01">347700.03</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c08aaa1c-1c88-431b-a7f4-9e1a27ec702a">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-11-14" />
      <value currency="USD" value-date="2022-11-14">89807.79</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e49cb8b1-2fff-4bbc-9227-0bc83bdd90ff">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-11-14" />
      <value currency="USD" value-date="2022-11-14">-94891.03</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1bff2072-cb89-4c04-b33b-58884125b570">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-11-16" />
      <value currency="USD" value-date="2022-11-16">770901.79</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3598b630-2dd2-47fe-ba9e-bea399514fb1">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-11-16" />
      <value currency="USD" value-date="2022-11-16">-89807.79</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d1a0e300-501a-44f4-b6fa-59b6974b1f1e">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-24" />
      <value currency="USD" value-date="2022-11-24">9483.94</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="bc88672b-60c9-4404-97a3-ccae7c79f3e1">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-28" />
      <value currency="USD" value-date="2022-11-28">13950606.12</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d8fa94bf-b836-4a29-9d60-96b787d19d75">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-28" />
      <value currency="USD" value-date="2022-11-28">2418033.53</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a030400c-0a7f-4174-994f-f38f76ed157a">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-20" />
      <value currency="USD" value-date="2022-12-20">4500000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="52413ff4-25e0-4697-b6f4-0118d384a705">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-01-10" />
      <value currency="USD" value-date="2023-01-10">11978.86</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c4cad441-84fc-49fb-b412-bc29132870fc">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-01-10" />
      <value currency="USD" value-date="2023-01-10">144775.44</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b45eef42-92f8-4828-9002-b56fc4f76dba">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-01-12" />
      <value currency="USD" value-date="2023-01-12">1808329.87</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0ee4206b-590a-4f4d-b571-6f07309137d1">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-01-24" />
      <value currency="USD" value-date="2023-01-24">4553639.12</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5e5c4c43-07c4-4202-8eb0-1b21d35ed782">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-01" />
      <value currency="USD" value-date="2023-02-01">1701.19</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3708efcc-dda9-473f-9e39-e8feef69e20a">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-02" />
      <value currency="USD" value-date="2023-02-02">11180890.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0013c935-b977-4116-ab90-63f915326a52">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-03" />
      <value currency="USD" value-date="2023-02-03">2369905.32</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b9120ed5-2e51-4329-bf00-323230f43df4">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-03" />
      <value currency="USD" value-date="2023-02-03">-2369905.32</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5b09dcf3-d9d8-420e-b0ea-b2eef7839a6e">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-09" />
      <value currency="USD" value-date="2023-02-09">873.37</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="624b5d38-a386-432e-abdc-cb7e3f788539">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-09" />
      <value currency="USD" value-date="2023-02-09">-49322.55</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6b67d057-bf0c-49ab-ab31-c9e5022d0a3f">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-09" />
      <value currency="USD" value-date="2023-02-09">-2369905.32</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b0fdf678-ba02-4094-af24-854a16fbb933">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-09" />
      <value currency="USD" value-date="2023-02-09">2419227.87</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7cdfa04b-2190-4a6e-810c-9c299b2c17ae">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-10" />
      <value currency="USD" value-date="2023-02-10">26.18</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cabdac3d-61ba-4b51-83f1-eef56b2006ba">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-10" />
      <value currency="USD" value-date="2023-02-10">-2419227.87</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="53a1780b-fc1e-45e1-b44b-ac85e011cd5e">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-03-09" />
      <value currency="USD" value-date="2023-03-09">368573.90</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bc1e9e21-523e-4e75-96b3-6ea1aa3f4196">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-03-09" />
      <value currency="USD" value-date="2023-03-09">524339.70</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="be48311a-3b65-4840-9e13-a462923d7efb">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-03-09" />
      <value currency="USD" value-date="2023-03-09">-488985.11</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e6dcb18e-6767-4be5-9b0a-e2999dc569f6">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-03-09" />
      <value currency="USD" value-date="2023-03-09">-602088.99</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ca91dbb1-0380-4181-8ae1-9cb787a5b1ea">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-21" />
      <value currency="USD" value-date="2023-03-21">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d3da6630-75f6-49f3-bae3-e91bcdcc7b8e">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-04-11" />
      <value currency="USD" value-date="2023-04-11">49322.55</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="af7cf5ee-5c91-4040-a417-938acb20dbe2">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-05-09" />
      <value currency="USD" value-date="2023-05-09">1132098.63</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c2ceb5bb-4c18-4c27-aefe-c41644611141">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-05-09" />
      <value currency="USD" value-date="2023-05-09">-524339.70</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f6e99cdc-6cd1-47fa-aaaf-dc310f05c985">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-06-01" />
      <value currency="USD" value-date="2023-06-01">1689.44</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0e09c38f-9728-46ae-8271-40af3ad31205">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-06-06" />
      <value currency="USD" value-date="2023-06-06">-6500227.20</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c06230d0-0fc9-4859-944a-55e60b2ed65a">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-06-06" />
      <value currency="USD" value-date="2023-06-06">36241003.41</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="65670057-0a90-41b9-8647-f0e1e374f00a">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-08" />
      <value currency="USD" value-date="2023-06-08">9498868.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="420efe8e-d90d-436a-a0f3-a71116083dc9">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-15" />
      <value currency="USD" value-date="2023-06-15">10100.68</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="18e5b82f-f2d6-4893-9c2b-99cee86a1f6b">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-06-27" />
      <value currency="USD" value-date="2023-06-27">2369905.32</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="615907bc-d029-47d0-bb5d-31658e2fc3f3">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-29" />
      <value currency="USD" value-date="2023-06-29">1218552.44</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="352341f8-3834-477f-9972-139b1d91a528">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-06-30" />
      <value currency="USD" value-date="2023-06-30">-1689.44</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c918f6cc-6d98-417d-9a77-97a037ae4e4f">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-07-01" />
      <value currency="USD" value-date="2023-07-01">26249.71</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4572355a-e36e-434f-b542-19e537dacf4a">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-04" />
      <value currency="USD" value-date="2023-07-04">26.16</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="16af6e94-1358-4bf0-995c-eb518e634589">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-12" />
      <value currency="USD" value-date="2023-07-12">-26249.71</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="451fdfba-335d-42db-ae10-5591e1ee40d2">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-20" />
      <value currency="USD" value-date="2023-07-20">353594.80</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1038634d-db0d-4d3f-9c9d-d77155eb1fc9">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-23" />
      <value currency="USD" value-date="2023-07-23">50000.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a5da05c1-acd4-47f0-94d2-44a759c359ef">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-10" />
      <value currency="USD" value-date="2023-08-10">5804176.90</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c0bd92a8-bf97-46bb-845c-982c330767eb">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-10" />
      <value currency="USD" value-date="2023-08-10">13629486.64</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="21539de3-3691-42d0-83d3-dc3eb8a79d0f">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-24" />
      <value currency="USD" value-date="2023-08-24">1692.62</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="efe6962b-8747-44a7-8a90-8742ac05684c">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-05" />
      <value currency="USD" value-date="2023-09-05">23943.71</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="fd0a6144-79cf-4ba7-b1d2-6da5bc94009f">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-05" />
      <value currency="USD" value-date="2023-09-05">289381.62</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="26a1a92b-35e8-4a68-9c2c-b0b9b5e7f53d">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-14" />
      <value currency="USD" value-date="2023-09-14">-463485.88</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="903446f9-4e5c-4a8f-8e06-3ed83de4d6a7">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-14" />
      <value currency="USD" value-date="2023-09-14">-289381.62</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ed543699-a987-46d1-87ed-2fa009e9e55a">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-14" />
      <value currency="USD" value-date="2023-09-14">752867.50</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5d097fd0-673f-4642-bc8e-a833ad48507f">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-20" />
      <value currency="USD" value-date="2023-09-20">289381.61</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="6506f351-eded-4fd7-9ee7-1ea25434f120">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-09-20" />
      <value currency="USD" value-date="2023-09-20">289381.62</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fc00e246-a068-4910-8a7a-d34dc09d3a7a">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-26" />
      <value currency="USD" value-date="2023-09-26">-0.02</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2f064e6e-4c80-489f-be62-734fb3c13c98">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-10-03" />
      <value currency="USD" value-date="2023-10-03">-463485.89</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="920ed8f0-d0c2-49b7-8742-a8be6a00fb59">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-10-03" />
      <value currency="USD" value-date="2023-10-03">265730.49</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="04a28e17-040b-4830-8f7d-a6b92b9cacec">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-05" />
      <value currency="USD" value-date="2023-10-05">21522.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a8364083-8a90-40b1-8308-e6724ebbf1a0">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-11-01" />
      <value currency="USD" value-date="2023-11-01">3182387.12</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ab542d28-59e5-421f-b898-9bd3564839cf">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-11-01" />
      <value currency="USD" value-date="2023-11-01">-368573.90</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="29d6bdd9-9f4d-4834-83a8-5b4cdc0f4338">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-11-08" />
      <value currency="USD" value-date="2023-11-08">-244208.49</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9c5d6e11-e827-4dc8-b167-0c5d044d8147">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-11-08" />
      <value currency="USD" value-date="2023-11-08">384722.49</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="07fcfb65-dbd7-4ec6-8cae-bc32050bec14">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-16" />
      <value currency="USD" value-date="2023-11-16">1148002.87</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="273564a0-8654-42bc-94b3-d4fa4a52a6ff">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-16" />
      <value currency="USD" value-date="2023-11-16">2389083.45</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1e1d8e58-105e-4e8b-aed8-e887649c4562">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-21" />
      <value currency="USD" value-date="2023-11-21">9857.88</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="5d446d22-4d45-414c-b5e1-0abea6d83a71">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-11-29" />
      <value currency="USD" value-date="2023-11-29">21281.97</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3a81dbb6-abb0-437f-b224-0dd765bf9f6f">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-11-30" />
      <value currency="USD" value-date="2023-11-30">-21281.97</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c5a0f9f6-0ccf-4c71-b049-3faefbd55c50">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-12-01" />
      <value currency="USD" value-date="2023-12-01">606.79</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="38876635-c900-4d9b-a85e-ba34dd0970cb">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-03" />
      <value currency="USD" value-date="2023-12-03">-374864.61</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a8e241f5-1cc5-486e-8a5f-4d68ec493754">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-03" />
      <value currency="USD" value-date="2023-12-03">339977.88</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7e7676ee-0b28-4f54-805a-b513c6b249d4">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-12" />
      <value currency="USD" value-date="2023-12-12">-339977.88</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b58fd60e-9862-473e-8296-8327417c2ca6">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-12" />
      <value currency="USD" value-date="2023-12-12">290001.63</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="00cca8ba-2f17-48b8-9de7-657b3bc9fa63">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-19" />
      <value currency="USD" value-date="2023-12-19">48230.27</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="bdf88438-934b-4d6b-9180-9ecd8e129bae">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-19" />
      <value currency="USD" value-date="2023-12-19">3990.62</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="2eedb295-8315-4c64-b8fe-46da5658e12b">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-22" />
      <value currency="USD" value-date="2023-12-22">-606.79</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4e9f2a09-2f95-4074-8990-766a630857a5">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-09" />
      <value currency="USD" value-date="2024-01-09">9670.88</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="cc0d9799-1d83-409c-b524-feab6b470145">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-19" />
      <value currency="USD" value-date="2024-01-19">3186152.88</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ce2a28e5-16a0-4ce4-b809-e1b09a22198c">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-19" />
      <value currency="USD" value-date="2024-01-19">-3182387.12</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3b159876-41d8-4e29-9f69-78a606da238d">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-29" />
      <value currency="USD" value-date="2024-01-29">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="421f5480-0844-459d-a134-db29c58f8a5c">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-03-02" />
      <value currency="USD" value-date="2024-03-02">3124727.88</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6d0f480c-37a2-46b7-84e4-adc58cfbcf96">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-03-02" />
      <value currency="USD" value-date="2024-03-02">-3186152.88</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1a62da43-8750-4307-8eed-6e92b8efc8d7">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-03-21" />
      <value currency="USD" value-date="2024-03-21">694478.44</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="4050ce10-d0a4-4381-ad52-5bf9394e8455">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-03-23" />
      <value currency="USD" value-date="2024-03-23">-2542732.43</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d6fe6cfa-0f1b-4a36-8fd6-873f04a9f580">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-03-23" />
      <value currency="USD" value-date="2024-03-23">21752093.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9f82423c-38aa-4d3f-956d-40acc0197325">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-02" />
      <value currency="USD" value-date="2024-04-02">6699458.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="04f5bbc1-2446-432b-9246-ef077da07343">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-13" />
      <value currency="USD" value-date="2024-04-13">243284.79</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ddea034b-ed3f-461c-93ba-565278a98a84">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-13" />
      <value currency="USD" value-date="2024-04-13">-228109.86</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0551c871-e186-4725-9a1d-0afb06405dcf">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-16" />
      <value currency="USD" value-date="2024-04-16">72615.57</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a3273d6b-0ada-43a9-83ee-01435ae03512">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-07-01" />
      <value currency="USD" value-date="2024-07-01">143.27</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c9f259f0-ba06-4ca8-9b23-8c55198f8818">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-04" />
      <value currency="USD" value-date="2024-07-04">-143.27</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="42323bc6-d3d2-4084-a303-575d29a91095">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-30" />
      <value currency="USD" value-date="2024-07-30">8652.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b183238a-7241-4b3b-950a-34f87d10c12a">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-17" />
      <value currency="USD" value-date="2024-08-17">2418738.80</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e150ba21-b6a6-418b-a691-bd0edfcd892f">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-17" />
      <value currency="USD" value-date="2024-08-17">-2421597.44</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3e2f2de0-23bb-42f2-a02e-327c18a42d39">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-24" />
      <value currency="USD" value-date="2024-09-24">1922236.79</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="45bdfe4f-b5f6-4ac1-8615-ec9eb90997d0">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-28" />
      <value currency="USD" value-date="2024-09-28">172440.32</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8736bd55-b611-425e-8633-ef2977d2b71b">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-28" />
      <value currency="USD" value-date="2024-09-28">-170669.22</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cb9a80d3-8fc5-48fe-8a91-bb15674241c3">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-28" />
      <value currency="USD" value-date="2024-09-28">-1771.10</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aab6e56c-7935-49a7-b104-2ce883e7dd9b">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-30" />
      <value currency="USD" value-date="2024-09-30">-39690.23</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ecf08c06-4c54-4118-8900-de67163d49a1">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">39690.23</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="110970a4-a1f3-4fa9-9142-ca0d189cdd15">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-10-04" />
      <value currency="USD" value-date="2024-10-04">1771.10</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="23431a66-a6ba-413e-aad4-01b246e0af0a">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-11-07" />
      <value currency="USD" value-date="2024-11-07">-172440.32</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a16cb113-beb0-4080-aa47-cc4eea4cfe00">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-11-07" />
      <value currency="USD" value-date="2024-11-07">268780.76</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8d32b964-cf7e-437d-988b-645548c8360f">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-01-28" />
      <value currency="USD" value-date="2025-01-28">14079012.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b5253952-a681-463a-8274-948d17ac73ab">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-01-28" />
      <value currency="USD" value-date="2025-01-28">-15052635.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7d55fce0-c025-4a34-ac8d-cb997ec02ecb">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-30" />
      <value currency="USD" value-date="2025-01-30">4625942.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1b3e1753-d10c-4a30-acc4-a11a11fa2a02">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-08" />
      <value currency="USD" value-date="2025-02-08">-70844.47</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ca81be0b-1f90-4d32-9cf3-2c613cb5658a">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-08" />
      <value currency="USD" value-date="2025-02-08">-268780.76</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f0f8262e-006c-4421-813a-1304d5291d8e">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-08" />
      <value currency="USD" value-date="2025-02-08">339625.23</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="84b98f12-6338-49db-a78b-c66cbac3f893">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-02-13" />
      <value currency="USD" value-date="2025-02-13">119014.69</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9ef789af-727d-4b53-8ca9-1e990cdef3f0">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-02-13" />
      <value currency="USD" value-date="2025-02-13">70844.47</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8a540945-be2b-4d8c-8aab-fa379598ee0d">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">-3662477.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fe672821-93ff-4104-aab9-394575d02751">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">3662477.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="14a47d42-00c8-4b8f-8ac8-224ba8fd522a">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-22" />
      <value currency="USD" value-date="2025-10-22">-496502.01</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fe997642-6e5e-43a3-adaa-d97d976fe670">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-22" />
      <value currency="USD" value-date="2025-10-22">521149.91</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="56536217-efd5-42fa-b2ff-e6b960929b2f">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-11" />
      <value currency="USD" value-date="2025-11-11">3844505.78</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5bed09b0-a3c1-4784-85e8-1b8c6225d402">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-12" />
      <value currency="USD" value-date="2025-12-12">206867.19</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e77de375-ed23-46bf-818f-ef5cb4ac69bb">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-12" />
      <value currency="USD" value-date="2025-12-12">-521149.91</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8a8c6fb9-3103-48d5-a799-00222d31c4f1">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">50789.30</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9e4e027c-f6cc-44e6-9f0f-044921c737b3">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">-220610.54</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aca0c53e-c86e-47bf-a253-d25807a6ce54">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">247629.14</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="dc70fd71-87a6-4fd2-a95b-f4d7d68999ed">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">-27018.60</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0310abe1-0cd9-475b-bbf7-e59dba7e31ec">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-17" />
      <value currency="USD" value-date="2025-12-17">247629.14</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f0ed4286-4900-409b-9620-d6efebbc6e8d">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-17" />
      <value currency="USD" value-date="2025-12-17">-247629.14</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8872571e-85f0-4aae-93f2-516e4613321b">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-23" />
      <value currency="USD" value-date="2025-12-23">220610.54</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8889fd12-2f2f-44f7-b4a2-5e34889e4925">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-23" />
      <value currency="USD" value-date="2025-12-23">-247629.14</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0176dfb1-ef6a-417e-a043-db9564d1364f">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">27018.60</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="216c0778-657f-4ed7-8318-3f6036cf68e2">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-20" />
      <value currency="USD" value-date="2026-01-20">7294.86</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b1229379-8674-4a75-b682-c6adabfdd779">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-20" />
      <value currency="USD" value-date="2026-01-20">20691.42</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="001aa21b-c35d-4836-9d27-b752a3b104cf">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-24" />
      <value currency="USD" value-date="2026-02-24">95211.75</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="29d61bc7-581f-4b38-a33d-82bea9d5b6a5">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-06" />
      <value currency="USD" value-date="2026-03-06">145750.65</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6cfb69d0-489c-48a4-9a0b-61432c1d0202">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-06" />
      <value currency="USD" value-date="2026-03-06">-128091.61</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bb116997-0079-4562-b3b4-8684d18941ce">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-06" />
      <value currency="USD" value-date="2026-03-06">-17659.04</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5409ba4a-2a30-47ae-a4d0-1fcc52f031a6">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-07" />
      <value currency="USD" value-date="2026-03-07">-145750.65</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bdc2ee05-9ab0-4a95-9026-4dbe9ad0e0f3">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-07" />
      <value currency="USD" value-date="2026-03-07">122748.10</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e1ff1413-46d4-4727-af58-5cf2ea738cfa">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-03-13" />
      <value currency="USD" value-date="2026-03-13">17659.04</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f3e20095-deda-4d7e-ad7c-6a863b5cf67c">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-21" />
      <value currency="USD" value-date="2026-04-21">24398.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="60207ee3-9e46-4717-88b6-4a8b3d2e70db">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-25" />
      <value currency="USD" value-date="2026-04-25">-101000.79</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="74488e96-3a55-497f-bfad-86e21d1e82ff">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-25" />
      <value currency="USD" value-date="2026-04-25">101595.85</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c363c988-391e-4b80-9e00-5071b14074c3">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-25" />
      <value currency="USD" value-date="2026-04-25">-595.06</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1d132e3b-a957-4b98-9fb7-92fa14eb42f6">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-03" />
      <value currency="USD" value-date="2026-05-03">91178.60</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="50c73229-42fe-41e5-9c99-06baacd018ac">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-03" />
      <value currency="USD" value-date="2026-05-03">-122748.10</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a59dbfb6-74fa-4ed1-ba48-cb8365d3a2ac">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-05" />
      <value currency="USD" value-date="2026-05-05">9000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="fd8a7d9a-5f16-4fcf-9654-cdb2e8743af7">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-05-05" />
      <value currency="USD" value-date="2026-05-05">595.06</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="868ffd22-9ded-48c3-bb94-3eb8048cd898">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-03" />
      <value currency="USD" value-date="2026-06-03">81727.85</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d82f3f8f-6d25-4e2d-bd18-395db573340f">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-03" />
      <value currency="USD" value-date="2026-06-03">-91178.60</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f52d2afe-a1e5-4aac-8237-9949f274b145">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-16" />
      <value currency="USD" value-date="2026-06-16">13222.50</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="043c46b1-42f1-4d1f-9db9-4df796040ebd">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-20" />
      <value currency="USD" value-date="2026-06-20">-79373.35</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="394a3c82-6d1a-4ce8-b811-8ee226bbf2e6">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-20" />
      <value currency="USD" value-date="2026-06-20">74373.36</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="27a1a14c-99aa-41c9-a557-fff6619be1ae">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-01" />
      <value currency="USD" value-date="2026-07-01">1648.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1dc310fd-e6ec-4e8c-aa14-3d7440778cd3">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-11" />
      <value currency="USD" value-date="2026-07-11">-48304.35</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c8611753-24c6-40f8-a09e-25826ec5064e">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-11" />
      <value currency="USD" value-date="2026-07-11">41712.35</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6613a407-9041-43f3-ba10-72331f026e5f">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-14" />
      <value currency="USD" value-date="2026-07-14">31775.50</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1d292f3d-8c7a-4c22-b94e-033c6d18314c">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-04" />
      <value currency="USD" value-date="2026-08-04">37582.15</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9030eb29-f58f-404b-8e74-7cdcceb6ad85">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-04" />
      <value currency="USD" value-date="2026-08-04">-41712.35</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="595a9a1a-dc57-44fb-8698-011d5e323d89">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-29" />
      <value currency="USD" value-date="2026-08-29">5608565.22</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ea7dfdef-d54b-405f-a1d6-8b298c395c61">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-29" />
      <value currency="USD" value-date="2026-08-29">-5608564.22</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7cb4ed07-2f86-4b63-833f-4da4190a3ea0">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-20" />
      <value currency="USD" value-date="2026-09-20">-37582.15</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP03-EXP-20211231">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-12-31">37080352.59</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP03, Jan 2021 to Dec 2021.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP03-EXP-20221231">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-12-31">59071348.83</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP03, Jan 2022 to Dec 2022.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP03-EXP-20231231">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-12-31">62827858.77</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP03, Jan 2023 to Dec 2023.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP03-EXP-20240630">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-06-30" />
      <value currency="USD" value-date="2024-06-30">-3932275.27</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP03, Jan 2024 to Jun 2024.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP03-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">5414730.44</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP03, Jul 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP03-EXP-20250630">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">7860767.47</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP03, Jan 2025 to Jun 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP03-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">14022038.46</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP03, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/PHL-T-PBSP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/PHL/2020/Tuberculosis/en/PHL-T_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 1 - Tuberculosis - Philippines - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR688-PHL-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2020-03-23" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of PSA plants installed with Global Fund investments and functional</narrative>
      </title>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of PSA plants installed with Global Fund investments and functional</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 0; Denominator: 0.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1; Denominator: 1; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of districts reporting events (per national guidelines)</narrative>
      </title>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of districts reporting events (per national guidelines)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="61.44">
          <comment>
            <narrative>Numerator: 1004; Denominator: 1634.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="70.01">
            <comment>
              <narrative>Numerator: 1144; Denominator: 1634.</narrative>
            </comment>
          </target>
          <actual value="25.19">
            <comment>
              <narrative>Numerator: 433; Denominator: 1719.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="79.99">
            <comment>
              <narrative>Numerator: 1307; Denominator: 1634.</narrative>
            </comment>
          </target>
          <actual value="25.19">
            <comment>
              <narrative>Numerator: 433; Denominator: 1719.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units which digitally enter and submit data at the reporting unit level using the electronic information system</narrative>
      </title>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units which digitally enter and submit data at the reporting unit level using the electronic information system</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="84.08">
          <comment>
            <narrative>Numerator: 3438; Denominator: 4089.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="85.01">
            <comment>
              <narrative>Numerator: 3476; Denominator: 4089.</narrative>
            </comment>
          </target>
          <actual value="25.52">
            <comment>
              <narrative>Numerator: 554; Denominator: 2171.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3680; Denominator: 4089.</narrative>
            </comment>
          </target>
          <actual value="25.52">
            <comment>
              <narrative>Numerator: 554; Denominator: 2171.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="6681" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="4644" />
          <actual value="3177" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="9288" />
          <actual value="6447" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="4644" />
          <actual value="3270" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="5327" />
          <actual value="4108" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="10655" />
          <actual value="8207" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="5328" />
          <actual value="4099" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="11713" />
          <actual value="8540" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="5856" />
          <actual value="4179" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="5857" />
          <actual value="4361" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="6284" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="4180" />
          <actual value="3038" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="8360" />
          <actual value="6081" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="4180" />
          <actual value="3043" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="5061" />
          <actual value="3931" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="10123" />
          <actual value="8235" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="5062" />
          <actual value="4304" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="5563" />
          <actual value="4229" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="11127" />
          <actual value="8345" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="5564" />
          <actual value="4116" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="40.43">
          <comment>
            <narrative>Numerator: 133514; Denominator: 330216.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="70">
            <comment>
              <narrative>Numerator: 164711; Denominator: 235302.</narrative>
            </comment>
          </target>
          <actual value="87.1">
            <comment>
              <narrative>Numerator: 87365; Denominator: 100288.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 329422; Denominator: 470604.</narrative>
            </comment>
          </target>
          <actual value="86.3">
            <comment>
              <narrative>Numerator: 201486; Denominator: 233527.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 164711; Denominator: 235302.</narrative>
            </comment>
          </target>
          <actual value="85.7">
            <comment>
              <narrative>Numerator: 114121; Denominator: 133239.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 197330; Denominator: 246663.</narrative>
            </comment>
          </target>
          <actual value="86.5">
            <comment>
              <narrative>Numerator: 148286; Denominator: 171361.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 394660; Denominator: 493326.</narrative>
            </comment>
          </target>
          <actual value="79.8">
            <comment>
              <narrative>Numerator: 335483; Denominator: 420364.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 197330; Denominator: 246663.</narrative>
            </comment>
          </target>
          <actual value="75.2">
            <comment>
              <narrative>Numerator: 187197; Denominator: 249003.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 456578; Denominator: 507308.</narrative>
            </comment>
          </target>
          <actual value="85.9">
            <comment>
              <narrative>Numerator: 370580; Denominator: 431199.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 228289; Denominator: 253654.</narrative>
            </comment>
          </target>
          <actual value="83.1">
            <comment>
              <narrative>Numerator: 179525; Denominator: 216150.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 228289; Denominator: 253654.</narrative>
            </comment>
          </target>
          <actual value="88.8">
            <comment>
              <narrative>Numerator: 191055; Denominator: 215049.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of confirmed RR/MDR-TB cases tested for resistance to second-line drugs</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of confirmed RR/MDR-TB cases tested for resistance to second-line drugs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="92.71">
          <comment>
            <narrative>Numerator: 5826; Denominator: 6284.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 4180; Denominator: 4644.</narrative>
            </comment>
          </target>
          <actual value="94.6">
            <comment>
              <narrative>Numerator: 3007; Denominator: 3177.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 8360; Denominator: 9288.</narrative>
            </comment>
          </target>
          <actual value="92.8">
            <comment>
              <narrative>Numerator: 5985; Denominator: 6447.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 4180; Denominator: 4644.</narrative>
            </comment>
          </target>
          <actual value="91.1">
            <comment>
              <narrative>Numerator: 2978; Denominator: 3270.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 10123; Denominator: 10654.</narrative>
            </comment>
          </target>
          <actual value="98.9">
            <comment>
              <narrative>Numerator: 8115; Denominator: 8207.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="95.01">
            <comment>
              <narrative>Numerator: 5061; Denominator: 5327.</narrative>
            </comment>
          </target>
          <actual value="94.8">
            <comment>
              <narrative>Numerator: 3893; Denominator: 4108.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="95.03">
            <comment>
              <narrative>Numerator: 5062; Denominator: 5327.</narrative>
            </comment>
          </target>
          <actual value="103">
            <comment>
              <narrative>Numerator: 4222; Denominator: 4099.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 5563; Denominator: 5856.</narrative>
            </comment>
          </target>
          <actual value="98.5">
            <comment>
              <narrative>Numerator: 4114; Denominator: 4178.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 11126; Denominator: 11712.</narrative>
            </comment>
          </target>
          <actual value="95.4">
            <comment>
              <narrative>Numerator: 8150; Denominator: 8539.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 5563; Denominator: 5856.</narrative>
            </comment>
          </target>
          <actual value="92.5">
            <comment>
              <narrative>Numerator: 4036; Denominator: 4361.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="99.45">
          <comment>
            <narrative>Numerator: 3085; Denominator: 3130.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="99">
            <comment>
              <narrative>Numerator: 3071; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="63.7">
            <comment>
              <narrative>Numerator: 2161; Denominator: 3394.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 6142; Denominator: 6204.</narrative>
            </comment>
          </target>
          <actual value="72.1">
            <comment>
              <narrative>Numerator: 4825; Denominator: 6691.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 3071; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="80.8">
            <comment>
              <narrative>Numerator: 2664; Denominator: 3297.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 6204; Denominator: 6204.</narrative>
            </comment>
          </target>
          <actual value="95.8">
            <comment>
              <narrative>Numerator: 6189; Denominator: 6463.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3102; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="91.7">
            <comment>
              <narrative>Numerator: 3026; Denominator: 3300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3102; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 3163; Denominator: 3163.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 6204; Denominator: 6204.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 6343; Denominator: 6343.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3102; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 3180; Denominator: 3180.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3102; Denominator: 3102.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 3163; Denominator: 3163.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="4526" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="18456" />
          <actual value="12721" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="6728" />
          <actual value="3364" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="11728" />
          <actual value="9357" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="22456" />
          <actual value="40594" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="11228" />
          <actual value="16301" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="11228" />
          <actual value="24293" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="13228" />
          <actual value="23945" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="26456" />
          <actual value="49156" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="13228" />
          <actual value="25211" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="3676" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="5400" />
          <actual value="4930" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="2700" />
          <actual value="2291" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="2700" />
          <actual value="2639" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="5130" />
          <actual value="4717" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="2565" />
          <actual value="2313" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="2565" />
          <actual value="2404" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="4874" />
          <actual value="5422" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="2437" />
          <actual value="2439" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="2437" />
          <actual value="2983" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="26032" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="18938" />
          <actual value="19490" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="75751" />
          <actual value="65221" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="56813" />
          <actual value="45731" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="51655" />
          <actual value="54925" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="106760" />
          <actual value="122732" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="55105" />
          <actual value="67807" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="120496" />
          <actual value="144501" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="60248" />
          <actual value="74054" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="60248" />
          <actual value="70447" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="371668" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="235302" />
          <actual value="98730" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="470604" />
          <actual value="268245" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="235302" />
          <actual value="169515" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="246663" />
          <actual value="199665" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="493326" />
          <actual value="444582" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="246663" />
          <actual value="244917" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="253654" />
          <actual value="288139" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="507308" />
          <actual value="593581" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="253654" />
          <actual value="305442" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="5939" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="4614" />
          <actual value="937" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="9228" />
          <actual value="3801" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="4614" />
          <actual value="2864" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="8084" />
          <actual value="5548" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="16168" />
          <actual value="18742" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="8084" />
          <actual value="13194" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="12963" />
          <actual value="16886" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="25926" />
          <actual value="35114" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="12963" />
          <actual value="18228" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="91">
          <comment>
            <narrative>Numerator: 287489; Denominator: 315923.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 205502; Denominator: 228336.</narrative>
            </comment>
          </target>
          <actual value="91.4">
            <comment>
              <narrative>Numerator: 82465; Denominator: 90187.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 411004; Denominator: 456672.</narrative>
            </comment>
          </target>
          <actual value="88.8">
            <comment>
              <narrative>Numerator: 169418; Denominator: 190793.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 205502; Denominator: 228336.</narrative>
            </comment>
          </target>
          <actual value="86.4">
            <comment>
              <narrative>Numerator: 86953; Denominator: 100606.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 423544; Denominator: 470604.</narrative>
            </comment>
          </target>
          <actual value="83.3">
            <comment>
              <narrative>Numerator: 229490; Denominator: 275603.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 211772; Denominator: 235302.</narrative>
            </comment>
          </target>
          <actual value="89.1">
            <comment>
              <narrative>Numerator: 106789; Denominator: 119789.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 211772; Denominator: 235302.</narrative>
            </comment>
          </target>
          <actual value="78.7">
            <comment>
              <narrative>Numerator: 122701; Denominator: 155814.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 221997; Denominator: 246663.</narrative>
            </comment>
          </target>
          <actual value="79.3">
            <comment>
              <narrative>Numerator: 174633; Denominator: 220305.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 443994; Denominator: 493326.</narrative>
            </comment>
          </target>
          <actual value="76.9">
            <comment>
              <narrative>Numerator: 397730; Denominator: 517339.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 221997; Denominator: 246663.</narrative>
            </comment>
          </target>
          <actual value="75.1">
            <comment>
              <narrative>Numerator: 223097; Denominator: 297034.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="95.78">
          <comment>
            <narrative>Numerator: 1134; Denominator: 1184.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 2982; Denominator: 2982.</narrative>
            </comment>
          </target>
          <actual value="96.9">
            <comment>
              <narrative>Numerator: 1326; Denominator: 1368.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1491; Denominator: 1491.</narrative>
            </comment>
          </target>
          <actual value="97.2">
            <comment>
              <narrative>Numerator: 700; Denominator: 720.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1491; Denominator: 1491.</narrative>
            </comment>
          </target>
          <actual value="96.6">
            <comment>
              <narrative>Numerator: 626; Denominator: 648.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1954; Denominator: 1954.</narrative>
            </comment>
          </target>
          <actual value="97.7">
            <comment>
              <narrative>Numerator: 795; Denominator: 814.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3908; Denominator: 3908.</narrative>
            </comment>
          </target>
          <actual value="98.2">
            <comment>
              <narrative>Numerator: 1967; Denominator: 2003.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1954; Denominator: 1954.</narrative>
            </comment>
          </target>
          <actual value="98.6">
            <comment>
              <narrative>Numerator: 1172; Denominator: 1189.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 2110; Denominator: 2110.</narrative>
            </comment>
          </target>
          <actual value="98.7">
            <comment>
              <narrative>Numerator: 1253; Denominator: 1270.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 4220; Denominator: 4220.</narrative>
            </comment>
          </target>
          <actual value="98.8">
            <comment>
              <narrative>Numerator: 2484; Denominator: 2514.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 2110; Denominator: 2110.</narrative>
            </comment>
          </target>
          <actual value="99">
            <comment>
              <narrative>Numerator: 1231; Denominator: 1244.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="52" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="70">
            <comment>
              <narrative>Numerator: 2601; Denominator: 3715.</narrative>
            </comment>
          </target>
          <actual value="63.9">
            <comment>
              <narrative>Numerator: 2161; Denominator: 3381.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 5202; Denominator: 7430.</narrative>
            </comment>
          </target>
          <actual value="65.6">
            <comment>
              <narrative>Numerator: 4989; Denominator: 7601.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 2601; Denominator: 3715.</narrative>
            </comment>
          </target>
          <actual value="67">
            <comment>
              <narrative>Numerator: 2828; Denominator: 4220.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 8362; Denominator: 11150.</narrative>
            </comment>
          </target>
          <actual value="70.5">
            <comment>
              <narrative>Numerator: 6903; Denominator: 9793.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="75">
            <comment>
              <narrative>Numerator: 4181; Denominator: 5575.</narrative>
            </comment>
          </target>
          <actual value="66.9">
            <comment>
              <narrative>Numerator: 3213; Denominator: 4803.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 4181; Denominator: 5575.</narrative>
            </comment>
          </target>
          <actual value="73.9">
            <comment>
              <narrative>Numerator: 3690; Denominator: 4990.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="80.01">
            <comment>
              <narrative>Numerator: 5243; Denominator: 6553.</narrative>
            </comment>
          </target>
          <actual value="75.1">
            <comment>
              <narrative>Numerator: 4109; Denominator: 5471.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 10486; Denominator: 13106.</narrative>
            </comment>
          </target>
          <actual value="76.1">
            <comment>
              <narrative>Numerator: 8070; Denominator: 10611.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="80.01">
            <comment>
              <narrative>Numerator: 5243; Denominator: 6553.</narrative>
            </comment>
          </target>
          <actual value="77.1">
            <comment>
              <narrative>Numerator: 3961; Denominator: 5140.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="27">
          <comment>
            <narrative>Numerator: 100350.36; Denominator: 371668.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="54">
            <comment>
              <narrative>Numerator: 89452; Denominator: 165653.</narrative>
            </comment>
          </target>
          <actual value="45.8">
            <comment>
              <narrative>Numerator: 48639; Denominator: 106266.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="54">
            <comment>
              <narrative>Numerator: 178904; Denominator: 331306.</narrative>
            </comment>
          </target>
          <actual value="47.1">
            <comment>
              <narrative>Numerator: 102830; Denominator: 218124.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="54">
            <comment>
              <narrative>Numerator: 89452; Denominator: 165653.</narrative>
            </comment>
          </target>
          <actual value="48.4">
            <comment>
              <narrative>Numerator: 54191; Denominator: 111858.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="72">
            <comment>
              <narrative>Numerator: 117214; Denominator: 162797.</narrative>
            </comment>
          </target>
          <actual value="61.6">
            <comment>
              <narrative>Numerator: 83875; Denominator: 136132.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="72">
            <comment>
              <narrative>Numerator: 234428; Denominator: 325594.</narrative>
            </comment>
          </target>
          <actual value="72">
            <comment>
              <narrative>Numerator: 236108; Denominator: 328086.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="72">
            <comment>
              <narrative>Numerator: 117214; Denominator: 162797.</narrative>
            </comment>
          </target>
          <actual value="79.3">
            <comment>
              <narrative>Numerator: 152233; Denominator: 191954.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 140626; Denominator: 156251.</narrative>
            </comment>
          </target>
          <actual value="90.3">
            <comment>
              <narrative>Numerator: 176662; Denominator: 195699.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 281252; Denominator: 312502.</narrative>
            </comment>
          </target>
          <actual value="92.3">
            <comment>
              <narrative>Numerator: 365306; Denominator: 395804.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 140626; Denominator: 156251.</narrative>
            </comment>
          </target>
          <actual value="94.3">
            <comment>
              <narrative>Numerator: 188644; Denominator: 200105.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T13:38:06+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-PHL-T-PBSP-4</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Advancing Client-centered Care and Expanding Sustainable Services for TB (ACCESS TB) Project - Philippines (01-Jan-2024-31-Dec-2026)</narrative>
    </title>
    <description type="1">
      <narrative>Philippines, Tuberculosis, Philippine Business for Social Progress, Inc.</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Decrease TB deaths by 50% from 54 in 2021 to 27 in 2026; Reduce TB catastrophic cost from 42% in 2017 to 0% in 2026; Achieve 90% patient satisfaction for TB services received. Objectives: Achieve 88% treatment success rate for all forms TB by 2026; Achieve 79% treatment coverage for all forms of TB by 2026.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Philippine Business for Social Progress, Inc.</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Philippine Business for Social Progress, Inc.</narrative>
    </participating-org>
    <other-identifier ref="PHL-T-PBSPP04" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-01-01" />
    <activity-date type="2" iso-date="2024-01-01" />
    <activity-date type="3" iso-date="2026-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Bryan Morris</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>bryan.morris@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="PH" percentage="100">
      <narrative>Philippines</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="79.95">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="20.05">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="11.65">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="80d429dc-894d-4f0c-99cc-2403b8f1f5fe" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: HRH planning, management and governance including for community health workers (CHWs)</narrative>
        </description>
      </budget-item>
      <budget-item code="a964bfef-7776-4f8c-bf11-c2f904336a18" percentage="3.03">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Specimen referral and transport system</narrative>
        </description>
      </budget-item>
      <budget-item code="7dbf6454-4357-4937-89a1-9a1c7f0174fa" percentage="1.08">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="8c042996-0cb7-4540-ad17-483cf18ec784" percentage="0.29">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="12d82614-1fc1-4696-b954-b899115b31d9" percentage="0.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
        </description>
      </budget-item>
      <budget-item code="4f5c256c-b6d1-40ea-9bd7-f061f042bc98" percentage="0.06">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Health financing strategies and planning</narrative>
        </description>
      </budget-item>
      <budget-item code="78165abf-6e6d-46ad-b445-d380c1037123" percentage="0.08">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
        </description>
      </budget-item>
      <budget-item code="31d3a0e8-e9f1-4c88-b1b7-ce75b4e952eb" percentage="0.66">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity, design &amp; operations</narrative>
        </description>
      </budget-item>
      <budget-item code="0e90e07b-37cc-4294-9a44-c1afd707a824" percentage="0.32">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; Integration/coordination across disease programs and at the service delivery level</narrative>
        </description>
      </budget-item>
      <budget-item code="69e672f0-6d26-46e7-8e97-fcb0b6526cb4" percentage="0.58">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; National health sector strategy, policy &amp; regulations</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="1.76">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="1a5ab4c7-9695-4567-adb4-0a3768fa01ee" percentage="0.51">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="95211519-fdf1-4ae4-964d-27e8afa798cf" percentage="0.47">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Community-based TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="1da38701-f878-40c8-aeaf-621a89991324" percentage="8.19">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Private provider engagement in TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="6.77">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="26.07">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="03989069-d574-46fc-9fad-200e03cde744" percentage="0.31">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="99e62de4-459a-4fc3-a5da-f5297d23736d" percentage="2.91">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - People in prisons/jails/detention centers</narrative>
        </description>
      </budget-item>
      <budget-item code="8d2f8312-6339-4e40-9c64-84e09bb628b3" percentage="25.35">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Urban poor/slum dwellers</narrative>
        </description>
      </budget-item>
      <budget-item code="23608000-3108-4c67-92d0-b1a31eb68b3f" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Eliminating TB-related stigma and discrimination</narrative>
        </description>
      </budget-item>
      <budget-item code="a690df09-3265-4854-a83c-e358df086817" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Ensuring people-centered and rights-based law enforcement practices</narrative>
        </description>
      </budget-item>
      <budget-item code="4cd951bf-504b-4a56-bbf4-1300accaaa5d" percentage="0.08">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Increasing access to justice (TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="2f74d6d7-267e-4393-87f1-d47588e1025c" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Monitoring and reforming policies, regulations and laws</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="4.87">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="897b3d08-9a6f-4d26-89e2-f762e49dad11" percentage="2.66">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Preventive treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="8f363382-1b81-4d2d-a396-2be1435016f2" percentage="1.64">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="602586f6-9a77-484c-bf39-acc8a3151170" percentage="0.25">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="0.38">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">38724512.92</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">46310998.93</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">35032542.63</value>
    </budget>
    <capital-spend percentage="3.19" />
    <transaction ref="cfc574d7-1044-4cfc-b253-b21e19785980">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-11-24" />
      <value currency="USD" value-date="2023-11-24">63796257.87</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ec6ad978-05e7-4624-b145-40af9c858eee">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-28" />
      <value currency="USD" value-date="2023-11-28">2969671.36</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c4aed19d-2418-4da8-96f7-b6243d64ba0a">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-07" />
      <value currency="USD" value-date="2023-12-07">11528792.60</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="507ec2a5-04b5-4b26-9b6b-b6b303974179">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-02-22" />
      <value currency="USD" value-date="2024-02-22">31923.43</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e6600711-d653-4ba1-bd84-4a3abf405600">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-05-08" />
      <value currency="USD" value-date="2024-05-08">6523535.41</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a2614c38-f37b-4128-b483-79592a1d5098">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-23" />
      <value currency="USD" value-date="2024-07-23">6497686.95</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="498c0882-a229-4411-a7c2-50f83ad00221">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-06" />
      <value currency="USD" value-date="2024-08-06">5815245.51</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3d7ca4a8-75d5-45d7-be16-afe79e14d997">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-09-01" />
      <value currency="USD" value-date="2024-09-01">5428.33</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d4419f64-19d6-4e7d-a0ed-465050a9829e">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-09-01" />
      <value currency="USD" value-date="2024-09-01">4394.78</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e84fff5d-d66a-4213-9d6f-85a933879df5">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-21" />
      <value currency="USD" value-date="2024-09-21">70208.35</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="900d575c-8055-4828-8154-91449febd88d">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-24" />
      <value currency="USD" value-date="2024-09-24">-5428.33</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f9f14b68-dde2-4ff6-86b6-9b8f51c6ab8f">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-26" />
      <value currency="USD" value-date="2024-09-26">6157001.68</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f4e8d016-4a43-44c4-af5d-5abb4eabe15c">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-27" />
      <value currency="USD" value-date="2024-09-27">-4394.78</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7859c2e2-249c-4be0-8957-3aaea1c41139">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">388157.49</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ceebeaca-00cf-458b-8ae6-e4f27cfdc0d2">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">-70208.35</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8e2688ed-25eb-4609-a09e-b287ebdbf6c0">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-17" />
      <value currency="USD" value-date="2024-10-17">126942.49</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0a1e7eb8-e15a-4d3c-a383-0a4df1ab144f">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-28" />
      <value currency="USD" value-date="2024-11-28">9233884.71</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7899f3e4-de0b-4009-aadf-cb519609fd27">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-02-04" />
      <value currency="USD" value-date="2025-02-04">1697.36</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="93f077c0-b832-45b2-9acd-022f0771e0b2">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-03-01" />
      <value currency="USD" value-date="2025-03-01">75956.96</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4f46f51b-5041-4ec6-83a6-cd466664cd1a">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-04" />
      <value currency="USD" value-date="2025-03-04">2512401.26</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="40ff6bdd-91f1-4973-9b4e-8413c4a58fe5">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-18" />
      <value currency="USD" value-date="2025-03-18">8295185.88</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="75ae438c-8078-4b9f-a09c-a1aa4b623d5e">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-20" />
      <value currency="USD" value-date="2025-03-20">9137.01</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1e1e29b0-1a90-4df9-a604-92bc80badfa1">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-26" />
      <value currency="USD" value-date="2025-03-26">-75956.96</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b9674eb9-c595-4739-9c3e-975ea8f257f9">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-01" />
      <value currency="USD" value-date="2025-04-01">10130.53</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a13ecbb9-271f-4a6e-bb43-0dba00974b39">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-28" />
      <value currency="USD" value-date="2025-05-28">-89.07</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a5145ce7-2320-4c62-9b14-deab78e29d68">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-28" />
      <value currency="USD" value-date="2025-05-28">240339.17</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="afe21bde-f79b-4598-bfb5-4b73e1709820">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-28" />
      <value currency="USD" value-date="2025-05-28">-240250.10</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fd13bc10-b5d1-4218-a446-24b0ac423aac">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-01" />
      <value currency="USD" value-date="2025-06-01">1540.78</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7bcfe320-687a-4fec-8689-546096fbfeed">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-05" />
      <value currency="USD" value-date="2025-06-05">89.07</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ed2dbb36-a286-489c-8c25-e4fe4045726b">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-06" />
      <value currency="USD" value-date="2025-06-06">-1540.78</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="40163c1f-b745-42e4-9ef6-66ff460613ce">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">3662477.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7191cb90-905e-4b29-afbd-5010b317533a">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">3662477.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d8370936-5582-4181-aa32-40cbdf0284ef">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-01" />
      <value currency="USD" value-date="2025-07-01">126276.13</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="dce95e9a-9dba-4b16-85a8-60bce083ef88">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-01" />
      <value currency="USD" value-date="2025-07-01">1576.26</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8973c26f-d126-4997-9ae5-b344de26fc01">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-01" />
      <value currency="USD" value-date="2025-07-01">23743565.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8d3425ee-703c-4952-b432-6adea65b7700">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-01" />
      <value currency="USD" value-date="2025-07-01">-4230929.08</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1a24c8f3-01b3-429d-8c98-717a9752557f">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-14" />
      <value currency="USD" value-date="2025-07-14">61456.90</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="269b22d8-2ff7-4b22-a9bc-a311a3ef478c">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-14" />
      <value currency="USD" value-date="2025-07-14">-112486.78</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fe211d94-0930-4e14-9be0-6410d525d8a7">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-22" />
      <value currency="USD" value-date="2025-07-22">7410557.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8735cce1-5de8-45c4-a47c-94380964bd01">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-16" />
      <value currency="USD" value-date="2025-08-16">-61456.90</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="afbe47fb-fa18-4ba3-ab71-2e6e77ecbcaa">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-09-01" />
      <value currency="USD" value-date="2025-09-01">127479.79</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1ac44518-a722-4f5e-8dc9-4e79fa256688">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-10" />
      <value currency="USD" value-date="2025-09-10">-127479.79</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aef21ae0-dc54-4d0c-96bf-4e0273c67089">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-23" />
      <value currency="USD" value-date="2025-09-23">474063.74</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="40b3e962-3b4f-4a13-886f-a29371d86783">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-01" />
      <value currency="USD" value-date="2025-10-01">8173799.98</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b03d6ac5-6360-4ea6-98ad-055c49a7156a">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-21" />
      <value currency="USD" value-date="2025-10-21">7791.45</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7bdcbb9e-d3e4-478f-9637-3efdfacb01f2">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-12-10" />
      <value currency="USD" value-date="2025-12-10">250085.05</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7fd9ba40-fae4-46b0-a89c-d96eeab73fe1">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-18" />
      <value currency="USD" value-date="2025-12-18">-250085.05</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1b3fbb74-9878-4743-a741-e46be54254c1">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-19" />
      <value currency="USD" value-date="2025-12-19">27018.60</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4c75aec2-dc6b-492c-a99a-d2f63e9c9e20">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">17292.97</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="ebea7abc-c303-41be-9c56-9eefa7bf4155">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">9725.63</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c07374d6-6108-4682-9f89-f54364a40492">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-27" />
      <value currency="USD" value-date="2026-01-27">11850.06</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="52c110b1-488c-4e7d-a51e-dd49ba98752a">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-29" />
      <value currency="USD" value-date="2026-01-29">-7677352.83</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5c680a1e-81ed-4c26-88ff-b0cbfa6da54c">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-29" />
      <value currency="USD" value-date="2026-01-29">35885673.10</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="34e573e4-74e0-4a19-a668-8980a06181b7">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-03" />
      <value currency="USD" value-date="2026-02-03">8741075.82</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bd6c4e7f-8987-4807-b4fb-3954c483623b">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-03-01" />
      <value currency="USD" value-date="2026-03-01">167723.74</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a301ca13-1966-444b-990d-c952cb84715b">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-12" />
      <value currency="USD" value-date="2026-03-12">-167723.74</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fba8ca2f-a744-4da1-b08d-3ed5965d3e94">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-08" />
      <value currency="USD" value-date="2026-04-08">611600.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e00fa2cd-6b7c-41bd-ae48-702cf36ee74c">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-21" />
      <value currency="USD" value-date="2026-04-21">2768982.03</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="69f12f48-a729-49c0-b4a7-3169056127b2">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">17813.03</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7306bd95-8712-4341-8315-470c2f206afe">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">-11850.06</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="eaec7f49-35f9-428b-90ae-6482fb41c458">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-06-01" />
      <value currency="USD" value-date="2026-06-01">102273.37</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ace9085e-9ea8-4c03-950c-0addeca12436">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-03" />
      <value currency="USD" value-date="2026-06-03">1581572.34</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cfa74c74-e66b-4ec3-b9a2-88d9814dd35d">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-03" />
      <value currency="USD" value-date="2026-06-03">1000000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4b7d0a94-cbc5-40ca-9cac-6bbf1b8fd2ff">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-04" />
      <value currency="USD" value-date="2026-06-04">-17813.03</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cda3031d-ad84-4973-adda-ffbffa5650fb">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-04" />
      <value currency="USD" value-date="2026-06-04">311560.87</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8eb148d8-fc40-4628-aba2-a73180da4c30">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-08" />
      <value currency="USD" value-date="2026-06-08">-102273.37</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="078b45d5-f632-400a-885a-14748463c043">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-09" />
      <value currency="USD" value-date="2026-06-09">7500000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7145ff67-4998-4dc3-8d1a-141d80a1d4ea">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-01" />
      <value currency="USD" value-date="2026-07-01">52867.79</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b18f2a09-a188-4f13-ae08-1ce2cd1e677e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-14" />
      <value currency="USD" value-date="2026-07-14">109619.04</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0fc0c5e6-2306-45e1-b2e6-ed572e7ff3af">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-15" />
      <value currency="USD" value-date="2026-07-15">195978.86</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3c899842-b5bc-4f8a-bfaf-1062a01dd25f">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-15" />
      <value currency="USD" value-date="2026-07-15">-201941.83</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cd4adc1e-f805-48bc-b41a-804d22d98c56">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-28" />
      <value currency="USD" value-date="2026-07-28">109619.03</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8a95c0c6-55cd-42d1-abbf-ea976a1edf6d">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-04" />
      <value currency="USD" value-date="2026-08-04">7850000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4819db99-f73f-42de-a1bc-4833b415f029">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-04" />
      <value currency="USD" value-date="2026-08-04">-611600.00</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9534c970-0b14-473a-a09a-0585520911c8">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-04" />
      <value currency="USD" value-date="2026-08-04">618189.44</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ea6ca658-efb9-4a1d-a527-fae7fdde5b60">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-11" />
      <value currency="USD" value-date="2026-08-11">52997.88</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="49bbc260-8914-4df5-b110-967c1a09f1b6">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-14" />
      <value currency="USD" value-date="2026-08-14">-618189.44</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c08fd4bc-461b-4cb9-a2e1-3dcccea0e99b">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-14" />
      <value currency="USD" value-date="2026-08-14">1880676.90</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="58d12212-42f6-474e-aef7-bbd7c802cd89">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-25" />
      <value currency="USD" value-date="2026-08-25">227700.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="2908a5f5-8a6e-4a54-a26e-ec36387525db">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-27" />
      <value currency="USD" value-date="2026-08-27">-86359.83</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b9109d67-161a-4d89-a67f-bb8b8300f0a6">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-27" />
      <value currency="USD" value-date="2026-08-27">94559.83</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b987abfd-0616-4e03-bef2-cea1de8e80c0">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-09-01" />
      <value currency="USD" value-date="2026-09-01">765.19</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="280d2961-7eb9-4c67-b3fb-72014bb43b5a">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-09" />
      <value currency="USD" value-date="2026-09-09">-765.19</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8bc48783-2372-4933-b224-d4badaac6d61">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">1000000.00</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0e741074-a3fc-4ce5-9b8e-853e07026f13">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-06" />
      <value currency="USD" value-date="2026-10-06">1284.29</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="05b5fe53-f544-464c-a348-2de7f46a2893">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-08" />
      <value currency="USD" value-date="2026-10-08">-109619.04</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aa531bbc-3124-4d86-ac6e-cdfd2693e8e1">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-08" />
      <value currency="USD" value-date="2026-10-08">202894.58</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ba3f0116-cdd5-4a16-8c78-1dcd25fc95f7">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-08" />
      <value currency="USD" value-date="2026-10-08">-93275.54</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0eec9d09-3fd6-4d9f-8c62-8871c52dc45b">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">-202894.58</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5eb88689-050d-4aaf-b89e-7e7ea66fde11">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">-109619.03</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e85e9fb8-4afd-4570-b9d5-3596dd88c746">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">312513.61</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aa3b06a1-b738-4ea4-8f4c-99294c075e4b">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-10-14" />
      <value currency="USD" value-date="2026-10-14">109619.04</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c0e63582-4c76-4ff6-8f62-cb62551e8ece">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-10-14" />
      <value currency="USD" value-date="2026-10-14">109619.03</value>
      <description>
        <narrative>Funds returned to the Global Fund from PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="06a9afdf-def4-474c-a507-9bbf21c1e7b1">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-15" />
      <value currency="USD" value-date="2026-10-15">96747.45</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e8f4fb15-3698-440c-8ae3-9585a24e24a5">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-15" />
      <value currency="USD" value-date="2026-10-15">96747.45</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="62e9747b-f62d-4807-a591-da23d996cc51">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-11-04" />
      <value currency="USD" value-date="2026-11-04">-312513.61</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="77a141b1-8b27-4d81-b300-c9bcba06a0b6">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-11-04" />
      <value currency="USD" value-date="2026-11-04">213544.96</value>
      <description>
        <narrative>Global Fund commitment to PHL-T-PBSPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0d190d54-4c73-4004-9b3d-eae22c7ff888">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-10" />
      <value currency="USD" value-date="2026-11-10">8258.52</value>
      <description>
        <narrative>Global Fund disbursement to PHL-T-PBSPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="PHL-T-PBSPP04-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">37876038.95</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP04, Jan 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <transaction ref="PHL-T-PBSPP04-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">36763457.46</value>
      <description>
        <narrative>Expenditure reported by Philippine Business for Social Progress, Inc. for PHL-T-PBSPP04, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Philippine Business for Social Progress, Inc.</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/PHL-T-PBSP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/PHL/2023/Tuberculosis/en/PHL-T_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 1 - Tuberculosis - Philippines - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1547-PHL-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-03-30" />
    </document-link>
    <conditions attached="1">
      <condition type="1">
        <narrative>1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons.</narrative>
      </condition>
      <condition type="1">
        <narrative>2 - With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation.</narrative>
      </condition>
      <condition type="2">
        <narrative>3 - Previously Disbursed Grant Funds The Program budget may be funded in part by Grant Funds disbursed under a previous Grant Agreement, which the Global Fund has approved to be used for the Program under the current Grant Agreement (“Previously Disbursed Grant Funds”), as well as additional Grant Funds up to the amount set forth in Section 3.6. hereof. Accordingly, the Global Fund may reduce the amount of Grant Funds set forth in Section 3.6. hereof by the amount of any Previously Disbursed Grant Funds. Previously Disbursed Grant Funds shall be governed by the terms of this Grant Agreement.</narrative>
      </condition>
      <condition type="1">
        <narrative>4 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of USD 27,204,036 for the Program (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction with the Host Country’s compliance with the requirements listed at 5.4(1)(a) and 5.4(1)(b) below (“Co-Financing Requirements”). The Grantee acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Host Country fails to: (a) progressively increase government expenditure on health to meet national universal health coverage goals; and/or (b) increase domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee acknowledges and agrees that the Host Country shall, as set out in the co-financing commitment letter dated 7 September 2023 (the “Commitment Letter”), unless otherwise agreed in writing with the Global Fund: (a) fulfil a total minimum co-financing commitment of USD 145,682,292; and (b) fulfil the programmatic commitments as stipulated in Section 1.3 of the Commitment Letter; and (c) provide to the Global Fund, evidence supporting achievement of the Co-Financing Requirements, including: (i) the approved Annual Procurement Plan from the Disease Prevention and Control Bureau for TB and RSSH for the upcoming year by no later than 31 December each year of the Implementation Period and the year following the end of the Implementation Period; and (ii) the Department of Health’s annual financial report showing total expenditure for TB and RSSH in the previous fiscal year by no later than 30 June each year of the Implementation Period and the year following the end of the Implementation Period.</narrative>
      </condition>
      <condition type="3">
        <narrative>5 - (1) Grant Funds may be used to pay for the services of an external auditor retained by the Global Fund for the annual independent audit of the Program (the “External Auditor”) and the Global Fund may disburse such Grant Funds directly to the External Auditor; (2) the Principal Recipient consents to the carrying out of audits of the Program by the External Auditor for the period covering fiscal years 2024 to 2026 inclusive (and other such additional periods as the Global Fund may communicate to the Principal Recipient in writing, and to the terms of reference of the External Auditor and agrees that such terms of reference may be amended from time to time; and (3) without limiting Section 7.5 of the Global Fund Grant Regulations (as amended from time to time), the Principal Recipient shall cooperate fully with the External Auditor to allow the External Auditor to perform its services, including by providing all information and documents requested by the External Auditor or the Global Fund.</narrative>
      </condition>
      <condition type="2">
        <narrative>6 - Procurement of second-line anti-TB drugs Unless otherwise notified by the Global Fund in writing, prior to the use of Grant Funds to finance the procurement of second-line anti-tuberculosis drugs and for each disbursement request that includes funds for the procurement of multi-drug resistant tuberculosis medicines, the Principal Recipient shall submit to the Global Fund and obtain the Global Fund’s written approval of a written confirmation of the price estimate and quantities of the second-line anti-tuberculosis drugs that will be procured by the Principal Recipient from the Global Drug Facility’s procurement agent.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector</narrative>
      </title>
      <description>
        <narrative>Module: Collaboration with other providers and sectors.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="22.94">
          <comment>
            <narrative>Numerator: 12935; Denominator: 56377.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="65" />
          <actual value="54.41">
            <comment>
              <narrative>Numerator: 80674; Denominator: 148273.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="65" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="65" />
          <actual value="60.52">
            <comment>
              <narrative>Numerator: 42568; Denominator: 70334.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="70" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="70" />
          <actual value="71.49">
            <comment>
              <narrative>Numerator: 101243; Denominator: 141625.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="70" />
          <actual value="74.55">
            <comment>
              <narrative>Numerator: 51294; Denominator: 68801.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="80" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="80" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="8235" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="5018" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="10036" />
          <actual value="8903" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="5018" />
          <actual value="3669" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="5887" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="11773" />
          <actual value="8374" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="5886" />
          <actual value="3953" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="6397.5" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="6397" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of RR/MDR-TB patients with DST results for Fluoroquinolone among the total number of notified RR/MDR-TB patients during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of RR/MDR-TB patients with DST results for Fluoroquinolone among the total number of notified RR/MDR-TB patients during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="98.59">
          <comment>
            <narrative>Numerator: 8119; Denominator: 8235.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="88.7">
            <comment>
              <narrative>Numerator: 6867; Denominator: 7742.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="93.82">
            <comment>
              <narrative>Numerator: 3337; Denominator: 3557.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="76.5">
            <comment>
              <narrative>Numerator: 6406; Denominator: 8374.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="67.34">
            <comment>
              <narrative>Numerator: 2783; Denominator: 4133.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 7850; Denominator: 8235; Percentage: 95.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4259; Denominator: 4304; Percentage: 98.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4259; Denominator: 4304; Percentage: 98.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 45; Denominator: 4304; Percentage: 1.05%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 45; Denominator: 4304; Percentage: 1.05%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1317; Denominator: 4304; Percentage: 30.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1317; Denominator: 4304; Percentage: 30.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 1663; Denominator: 4304; Percentage: 38.64%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 1663; Denominator: 4304; Percentage: 38.64%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2987; Denominator: 4304; Percentage: 69.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2987; Denominator: 4304; Percentage: 69.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 2641; Denominator: 4304; Percentage: 61.36%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 2641; Denominator: 4304; Percentage: 61.36%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7742; Denominator: 8903; Percentage: 86.96%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3557; Denominator: 3669; Percentage: 96.95%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 7616; Denominator: 8758; Percentage: 86.96%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 126; Denominator: 145; Percentage: 86.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 2289.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 1044.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 5453.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 6608.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7952; Denominator: 8374; Percentage: 94.96%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3711; Denominator: 3953; Percentage: 93.88%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 7826; Denominator: 8242; Percentage: 94.95%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 126; Denominator: 132; Percentage: 95.45%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 2403; Denominator: 2517; Percentage: 95.47%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 990.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 5549; Denominator: 5857; Percentage: 94.74%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 6775.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="73.5">
          <comment>
            <narrative>Numerator: 4146; Denominator: 5641.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="75" />
          <actual value="78.19">
            <comment>
              <narrative>Numerator: 3980; Denominator: 5090.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="75" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="75" />
          <actual value="79.8">
            <comment>
              <narrative>Numerator: 2086; Denominator: 2614.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="80" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="80" />
          <actual value="69.35">
            <comment>
              <narrative>Numerator: 3075; Denominator: 4434.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="80" />
          <actual value="66.93">
            <comment>
              <narrative>Numerator: 1435; Denominator: 2144.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="85" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="85" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among key affected populations/high risk groups (other than prisoners); *includes only those with new and relapse</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among key affected populations/high risk groups (other than prisoners); *includes only those with new and relapse</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="31689" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="20186" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="44158" />
          <actual value="55571" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="23972" />
          <actual value="28569" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="53100" />
          <actual value="71498" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="26550" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="26550" />
          <actual value="34450" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="29444" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="29444" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="4186" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="2500" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="5000" />
          <actual value="6099" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="2500" />
          <actual value="3443" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="4600" />
          <actual value="7211" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="2300" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="2300" />
          <actual value="3455" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="2000" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="2000" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units which digitally enter and submit data at the reporting unit level using the electronic information system</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Monitoring and evaluation systems.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units which digitally enter and submit data at the reporting unit level using the electronic information system</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="100">
          <comment>
            <narrative>Numerator: 3297; Denominator: 3297.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="89.09">
            <comment>
              <narrative>Numerator: 3472; Denominator: 3897.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="89.09">
            <comment>
              <narrative>Numerator: 3472; Denominator: 3897.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="93.43">
            <comment>
              <narrative>Numerator: 7350; Denominator: 7867.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="93.43">
            <comment>
              <narrative>Numerator: 7350; Denominator: 7867.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 476754.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 242265; Denominator: 263033; Percentage: 92.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 242265; Denominator: 263033; Percentage: 92.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 20768; Denominator: 263033; Percentage: 7.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 20768; Denominator: 263033; Percentage: 7.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 116085; Denominator: 263033; Percentage: 44.13%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 116085; Denominator: 263033; Percentage: 44.13%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 94776; Denominator: 263033; Percentage: 36.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 94776; Denominator: 263033; Percentage: 36.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 168257; Denominator: 263033; Percentage: 63.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 168257; Denominator: 263033; Percentage: 63.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 137575; Denominator: 263033; Percentage: 52.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 137575; Denominator: 263033; Percentage: 52.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 952; Denominator: 263033; Percentage: 0.36%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 952; Denominator: 263033; Percentage: 0.36%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 63045; Denominator: 263033; Percentage: 23.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 63045; Denominator: 263033; Percentage: 23.97%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 280359.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 560719.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 563335.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 280359.5.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 276435.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 513791.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 49503.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 250479.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 205003.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 358332.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 177477.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 2556.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 241313.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 598012.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 558403.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 299006.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 299006.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 275580.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 522371.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 36031.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 256566.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 99707.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 175872.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 360675.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 2505.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 195223.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 297855.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 297855.5.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="70.74">
          <comment>
            <narrative>Numerator: 337262; Denominator: 476754.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="75" />
          <actual value="74.25">
            <comment>
              <narrative>Numerator: 418261; Denominator: 563335.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="75" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="75" />
          <actual value="75.64">
            <comment>
              <narrative>Numerator: 209094; Denominator: 276435.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="78" />
          <actual value="87.42">
            <comment>
              <narrative>Numerator: 488154; Denominator: 558403.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="78" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="78" />
          <actual value="89.14">
            <comment>
              <narrative>Numerator: 245651; Denominator: 275580.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="80" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="80" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="20.82">
          <comment>
            <narrative>Numerator: 99240; Denominator: 476754.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="25" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="25" />
          <actual value="24.92">
            <comment>
              <narrative>Numerator: 140404; Denominator: 563335.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="25" />
          <actual value="24.58">
            <comment>
              <narrative>Numerator: 67956; Denominator: 276435.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="26" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="26" />
          <actual value="23.68">
            <comment>
              <narrative>Numerator: 132238; Denominator: 558403.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="26" />
          <actual value="23.23">
            <comment>
              <narrative>Numerator: 64028; Denominator: 275580.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="27" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="27" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="76.25">
          <comment>
            <narrative>Numerator: 206635; Denominator: 270987.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="75.64">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 118729; Denominator: 156965.11.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="75.64">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 118729; Denominator: 156965.11.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="63.8">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 8590; Denominator: 13463.89.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="63.8">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 8590; Denominator: 13463.89.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="69.76">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 42837; Denominator: 61405.57.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="69.76">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 42837; Denominator: 61405.57.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="77.49">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 84482; Denominator: 109023.43.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="77.49">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 84482; Denominator: 109023.43.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="63.38">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 56494; Denominator: 89134.37.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="63.38">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 56494; Denominator: 89134.37.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="87.2">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 535; Denominator: 613.54.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="87.2">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 535; Denominator: 613.54.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="76.11">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 61405; Denominator: 80681.09.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="76.11">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 61405; Denominator: 80681.09.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="84" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="84" />
          <actual value="85.19">
            <comment>
              <narrative>Numerator: 475629; Denominator: 558319.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="84" />
          <actual value="84.92">
            <comment>
              <narrative>Numerator: 237692; Denominator: 279886.</narrative>
            </comment>
          </actual>
          <actual value="45.29">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 215415; Denominator: 475629.</narrative>
            </comment>
          </actual>
          <actual value="4.68">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 22256; Denominator: 475629.</narrative>
            </comment>
          </actual>
          <actual value="18.44">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 87711; Denominator: 475629.</narrative>
            </comment>
          </actual>
          <actual value="31.53">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 149960; Denominator: 475629.</narrative>
            </comment>
          </actual>
          <actual value="0.09">
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 447; Denominator: 475629.</narrative>
            </comment>
          </actual>
          <actual value="0.23">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 1112; Denominator: 475629.</narrative>
            </comment>
          </actual>
          <actual value="41.27">
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 196271; Denominator: 475629.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="85" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="85" />
          <actual value="88.11">
            <comment>
              <narrative>Numerator: 493035; Denominator: 559562.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="85" />
          <actual value="88.06">
            <comment>
              <narrative>Numerator: 243690; Denominator: 276739.</narrative>
            </comment>
          </actual>
          <actual value="87.33">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 447348; Denominator: 512231.</narrative>
            </comment>
          </actual>
          <actual value="92.54">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 45673; Denominator: 49355.</narrative>
            </comment>
          </actual>
          <actual value="87.88">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 180090; Denominator: 204919.</narrative>
            </comment>
          </actual>
          <actual value="87.74">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 312931; Denominator: 356667.</narrative>
            </comment>
          </actual>
          <actual value="93.74">
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 339426; Denominator: 362090.</narrative>
            </comment>
          </actual>
          <actual value="86.2">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 2418; Denominator: 2805.</narrative>
            </comment>
          </actual>
          <actual value="77.29">
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 151191; Denominator: 195604.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="90" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 30492.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 11164; Denominator: 19721; Percentage: 56.61%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 11164; Denominator: 19721; Percentage: 56.61%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 4465; Denominator: 19721; Percentage: 22.64%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 4465; Denominator: 19721; Percentage: 22.64%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 4092; Denominator: 19721; Percentage: 20.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 4092; Denominator: 19721; Percentage: 20.75%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 106609.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 90157.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 53304.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 53304.5.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 50505.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 53949.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 16854.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 12655.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 183299.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 131044.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 91649.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 91649.5.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 72205.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 94114.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 23096.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 13834.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 146726.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 146726.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 1969; Denominator: 2001; Percentage: 98.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3684; Denominator: 3690; Percentage: 99.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3684; Denominator: 3690; Percentage: 99.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 6; Denominator: 3690; Percentage: 0.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 6; Denominator: 3690; Percentage: 0.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 0; Denominator: 3690; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 0; Denominator: 3690; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 115; Denominator: 3690; Percentage: 3.12%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 115; Denominator: 3690; Percentage: 3.12%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3575; Denominator: 3690; Percentage: 96.88%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3575; Denominator: 3690; Percentage: 96.88%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 95%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2790; Denominator: 2806; Percentage: 99.43%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 95%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1451; Denominator: 1465; Percentage: 99.04%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2790; Denominator: 2790; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 0; Denominator: 2790.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 0; Denominator: 2790.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 149; Denominator: 2790; Percentage: 5.34%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2641; Denominator: 2790; Percentage: 94.66%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 95%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2731; Denominator: 2780; Percentage: 98.24%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 95%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1383; Denominator: 1411; Percentage: 98.02%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2720; Denominator: 2768; Percentage: 98.27%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 4; Denominator: 4; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 7; Denominator: 8; Percentage: 87.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 165; Denominator: 169; Percentage: 97.63%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="7.97">
          <comment>
            <narrative>Numerator: 6699; Denominator: 84086.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 85809; Denominator: 100418.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="81.8">
            <comment>
              <narrative>Numerator: 92273; Denominator: 112814.</narrative>
            </comment>
          </target>
          <actual value="88.61">
            <comment>
              <narrative>Numerator: 80506; Denominator: 90854.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="5.73">
            <comment>
              <narrative>Numerator: 6464; Denominator: 112814.</narrative>
            </comment>
          </target>
          <actual value="7.73">
            <comment>
              <narrative>Numerator: 7026; Denominator: 90854.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="6.73">
            <comment>
              <narrative>Numerator: 10561; Denominator: 156820.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="13.5">
            <comment>
              <narrative>Numerator: 21122; Denominator: 156820.</narrative>
            </comment>
          </target>
          <actual value="12.89">
            <comment>
              <narrative>Numerator: 12974; Denominator: 100671.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="6.73">
            <comment>
              <narrative>Numerator: 10561; Denominator: 156820.</narrative>
            </comment>
          </target>
          <actual value="6.72">
            <comment>
              <narrative>Numerator: 6761; Denominator: 100671.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="6.03">
            <comment>
              <narrative>Numerator: 12378; Denominator: 205360.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="6.03">
            <comment>
              <narrative>Numerator: 12378; Denominator: 205360.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="71.95">
          <comment>
            <narrative>Numerator: 236152; Denominator: 328201.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="80" />
          <actual value="64.65">
            <comment>
              <narrative>Numerator: 364183; Denominator: 563335.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="80" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="80" />
          <actual value="49.6">
            <comment>
              <narrative>Numerator: 185941; Denominator: 374915.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="54.7" />
          <actual value="66.71">
            <comment>
              <narrative>Numerator: 372500; Denominator: 558403.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="85" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="54.72" />
          <actual value="69.55">
            <comment>
              <narrative>Numerator: 191656; Denominator: 275580.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="56.5" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="56.5" />
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>